Pathway Name	Pathway Id	Source Name	Organism	Pathway uploaded gene count	Genes in InnateDB for this entity	Pathway p-value	Pathway p-value (corrected)	Gene Symbols	Genes (Symbol|IDBG-ID|Ensembl|Entrez|Fold Change|P-Value)
Folding of actin by CCT/TriC	13423	REACTOME	9606	7	9	1.4640394383516872E-12	8.125418882851864E-10	CCT2; CCT3; CCT4; CCT5; CCT6A; CCT7; TCP1; 	CCT2|IDBG-47181|ENSG00000166226|10576|; CCT3|IDBG-103469|ENSG00000163468|7203|; CCT4|IDBG-53426|ENSG00000115484|10575|; CCT5|IDBG-12328|ENSG00000150753|22948|; CCT6A|IDBG-17442|ENSG00000146731|908|; CCT7|IDBG-56424|ENSG00000135624|10574|; TCP1|IDBG-98570|ENSG00000120438|677812,6950|; 
Formation of tubulin folding intermediates by CCT/TriC	13443	REACTOME	9606	8	21	8.733840622895331E-11	2.4236407728534544E-8	CCT2; CCT3; CCT4; CCT5; CCT6A; CCT7; TCP1; TUBA4A; 	CCT2|IDBG-47181|ENSG00000166226|10576|; CCT3|IDBG-103469|ENSG00000163468|7203|; CCT4|IDBG-53426|ENSG00000115484|10575|; CCT5|IDBG-12328|ENSG00000150753|22948|; CCT6A|IDBG-17442|ENSG00000146731|908|; CCT7|IDBG-56424|ENSG00000135624|10574|; TCP1|IDBG-98570|ENSG00000120438|677812,6950|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; 
Chromatin modifying enzymes	19015	REACTOME	9606	16	193	2.0600917060161427E-9	1.633358424055656E-7	CHD3; CHD4; EP300; GPS2; HDAC3; HIST2H2AC; HIST2H2BE; JAK2; KDM5D; MBIP; NCOR1; NCOR2; SMARCB1; TBL1X; TBL1XR1; WDR5; 	CHD3|IDBG-27053|ENSG00000170004|1107|; CHD4|IDBG-14532|ENSG00000111642|1108|; EP300|IDBG-8992|ENSG00000100393|2033|; GPS2|IDBG-24467|ENSG00000132522|2874|; HDAC3|IDBG-50725|ENSG00000171720|8841|; HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; JAK2|IDBG-47039|ENSG00000096968|3717|; KDM5D|IDBG-354|ENSG00000012817|8284|; MBIP|IDBG-4937|ENSG00000151332|51562|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; SMARCB1|IDBG-2584|ENSG00000099956|6598|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; WDR5|IDBG-91736|ENSG00000196363|11091|; 
Chromatin organization	18782	REACTOME	9606	16	193	2.0600917060161427E-9	1.633358424055656E-7	CHD3; CHD4; EP300; GPS2; HDAC3; HIST2H2AC; HIST2H2BE; JAK2; KDM5D; MBIP; NCOR1; NCOR2; SMARCB1; TBL1X; TBL1XR1; WDR5; 	CHD3|IDBG-27053|ENSG00000170004|1107|; CHD4|IDBG-14532|ENSG00000111642|1108|; EP300|IDBG-8992|ENSG00000100393|2033|; GPS2|IDBG-24467|ENSG00000132522|2874|; HDAC3|IDBG-50725|ENSG00000171720|8841|; HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; JAK2|IDBG-47039|ENSG00000096968|3717|; KDM5D|IDBG-354|ENSG00000012817|8284|; MBIP|IDBG-4937|ENSG00000151332|51562|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; SMARCB1|IDBG-2584|ENSG00000099956|6598|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; WDR5|IDBG-91736|ENSG00000196363|11091|; 
Prefoldin mediated transfer of substrate  to CCT/TriC	13442	REACTOME	9606	8	27	8.94751413502914E-10	1.6552901149803908E-7	CCT2; CCT3; CCT4; CCT5; CCT6A; CCT7; TCP1; TUBA4A; 	CCT2|IDBG-47181|ENSG00000166226|10576|; CCT3|IDBG-103469|ENSG00000163468|7203|; CCT4|IDBG-53426|ENSG00000115484|10575|; CCT5|IDBG-12328|ENSG00000150753|22948|; CCT6A|IDBG-17442|ENSG00000146731|908|; CCT7|IDBG-56424|ENSG00000135624|10574|; TCP1|IDBG-98570|ENSG00000120438|677812,6950|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; 
Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding	18485	REACTOME	9606	8	28	1.2395856601092372E-9	1.7199251034015667E-7	CCT2; CCT3; CCT4; CCT5; CCT6A; CCT7; TCP1; TUBA4A; 	CCT2|IDBG-47181|ENSG00000166226|10576|; CCT3|IDBG-103469|ENSG00000163468|7203|; CCT4|IDBG-53426|ENSG00000115484|10575|; CCT5|IDBG-12328|ENSG00000150753|22948|; CCT6A|IDBG-17442|ENSG00000146731|908|; CCT7|IDBG-56424|ENSG00000135624|10574|; TCP1|IDBG-98570|ENSG00000120438|677812,6950|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; 
Association of TriC/CCT with target proteins during biosynthesis	13422	REACTOME	9606	8	29	1.6939538009691863E-9	1.880288719075797E-7	CCT2; CCT3; CCT4; CCT5; CCT6A; CCT7; FBXO6; TCP1; 	CCT2|IDBG-47181|ENSG00000166226|10576|; CCT3|IDBG-103469|ENSG00000163468|7203|; CCT4|IDBG-53426|ENSG00000115484|10575|; CCT5|IDBG-12328|ENSG00000150753|22948|; CCT6A|IDBG-17442|ENSG00000146731|908|; CCT7|IDBG-56424|ENSG00000135624|10574|; FBXO6|IDBG-89462|ENSG00000116663|26270|; TCP1|IDBG-98570|ENSG00000120438|677812,6950|; 
NOTCH1 Intracellular Domain Regulates Transcription	13296	REACTOME	9606	9	45	3.504255906518179E-9	2.431077535146987E-7	EP300; HDAC3; NCOR1; NCOR2; TBL1X; TBL1XR1; TLE1; TLE2; UBC; 	EP300|IDBG-8992|ENSG00000100393|2033|; HDAC3|IDBG-50725|ENSG00000171720|8841|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Cellular responses to stress	16723	REACTOME	9606	17	240	6.897708670078607E-9	4.253587013215141E-7	CBX2; DNAJB1; EP300; HIST2H2AC; HIST2H2BE; HIST3H3; POT1; PRDX2; RNF2; SIRT1; SP1; SUZ12; TERF1; TERF2IP; UBC; VHL; YWHAE; 	CBX2|IDBG-71184|ENSG00000173894|84733|; DNAJB1|IDBG-33491|ENSG00000132002|3337|; EP300|IDBG-8992|ENSG00000100393|2033|; HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; POT1|IDBG-39151|ENSG00000128513|25913|; PRDX2|IDBG-31024|ENSG00000167815|7001|; RNF2|IDBG-105369|ENSG00000121481|6045|; SIRT1|IDBG-75847|ENSG00000096717|23411|; SP1|IDBG-36616|ENSG00000185591|6667|; SUZ12|IDBG-39777|ENSG00000178691|23512|; TERF1|IDBG-25349|ENSG00000147601|7013|; TERF2IP|IDBG-42783|ENSG00000166848|54386|; UBC|IDBG-64029|ENSG00000150991|7316|; VHL|IDBG-17819|ENSG00000134086|7428|; YWHAE|IDBG-14629|ENSG00000108953|7531|; 
Chaperonin-mediated protein folding	18121	REACTOME	9606	9	49	7.78921443072395E-9	4.323014009051792E-7	CCT2; CCT3; CCT4; CCT5; CCT6A; CCT7; FBXO6; TCP1; TUBA4A; 	CCT2|IDBG-47181|ENSG00000166226|10576|; CCT3|IDBG-103469|ENSG00000163468|7203|; CCT4|IDBG-53426|ENSG00000115484|10575|; CCT5|IDBG-12328|ENSG00000150753|22948|; CCT6A|IDBG-17442|ENSG00000146731|908|; CCT7|IDBG-56424|ENSG00000135624|10574|; FBXO6|IDBG-89462|ENSG00000116663|26270|; TCP1|IDBG-98570|ENSG00000120438|677812,6950|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; 
HDACs deacetylate histones	18573	REACTOME	9606	10	70	1.4169907296545097E-8	7.149362317802298E-7	CHD3; CHD4; GPS2; HDAC3; HIST2H2AC; HIST2H2BE; NCOR1; NCOR2; TBL1X; TBL1XR1; 	CHD3|IDBG-27053|ENSG00000170004|1107|; CHD4|IDBG-14532|ENSG00000111642|1108|; GPS2|IDBG-24467|ENSG00000132522|2874|; HDAC3|IDBG-50725|ENSG00000171720|8841|; HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; 
AndrogenReceptor	15906	NETPATH	9606	14	164	1.5483492293109748E-8	7.161115185563258E-7	AR; EGFR; EP300; ESR1; FOXA1; NCOA6; NCOR1; NCOR2; NSD1; SIRT1; SMAD3; SP1; SRY; UBE3A; 	AR|IDBG-73722|ENSG00000169083|367|; EGFR|IDBG-16933|ENSG00000146648|1956|; EP300|IDBG-8992|ENSG00000100393|2033|; ESR1|IDBG-97997|ENSG00000091831|2099|; FOXA1|IDBG-5104|ENSG00000129514|3169|; NCOA6|IDBG-68724|ENSG00000198646|23054|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; NSD1|IDBG-59534|ENSG00000165671|64324|; SIRT1|IDBG-75847|ENSG00000096717|23411|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SP1|IDBG-36616|ENSG00000185591|6667|; SRY|IDBG-1|ENSG00000184895|6736|; UBE3A|IDBG-4274|ENSG00000114062|7337|; 
Circadian Clock	13672	REACTOME	9606	9	55	2.2631843205427595E-8	8.971909270723083E-7	CRY2; CSNK1E; EP300; HDAC3; NCOA6; NCOR1; TBL1X; TBL1XR1; UBC; 	CRY2|IDBG-41167|ENSG00000121671|1408|; CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; EP300|IDBG-8992|ENSG00000100393|2033|; HDAC3|IDBG-50725|ENSG00000171720|8841|; NCOA6|IDBG-68724|ENSG00000198646|23054|; NCOR1|IDBG-31971|ENSG00000141027|9611|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Protein folding	16650	REACTOME	9606	9	55	2.2631843205427595E-8	8.971909270723083E-7	CCT2; CCT3; CCT4; CCT5; CCT6A; CCT7; FBXO6; TCP1; TUBA4A; 	CCT2|IDBG-47181|ENSG00000166226|10576|; CCT3|IDBG-103469|ENSG00000163468|7203|; CCT4|IDBG-53426|ENSG00000115484|10575|; CCT5|IDBG-12328|ENSG00000150753|22948|; CCT6A|IDBG-17442|ENSG00000146731|908|; CCT7|IDBG-56424|ENSG00000135624|10574|; FBXO6|IDBG-89462|ENSG00000116663|26270|; TCP1|IDBG-98570|ENSG00000120438|677812,6950|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; 
Telomere Maintenance	17962	REACTOME	9606	9	64	8.916915714480495E-8	3.299258814357783E-6	HIST2H2AC; HIST2H2BE; HIST3H3; PCNA; POT1; PRIM1; PRIM2; TERF1; TERF2IP; 	HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; PCNA|IDBG-50801|ENSG00000132646|5111|; POT1|IDBG-39151|ENSG00000128513|25913|; PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; TERF1|IDBG-25349|ENSG00000147601|7013|; TERF2IP|IDBG-42783|ENSG00000166848|54386|; 
Regulation of Telomerase	15864	PID NCI	9606	9	65	1.0241663196864997E-7	3.552576921412546E-6	EGFR; ESR1; POT1; SMAD3; SP1; TERF1; TERF2IP; UBE3A; YWHAE; 	EGFR|IDBG-16933|ENSG00000146648|1956|; ESR1|IDBG-97997|ENSG00000091831|2099|; POT1|IDBG-39151|ENSG00000128513|25913|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SP1|IDBG-36616|ENSG00000185591|6667|; TERF1|IDBG-25349|ENSG00000147601|7013|; TERF2IP|IDBG-42783|ENSG00000166848|54386|; UBE3A|IDBG-4274|ENSG00000114062|7337|; YWHAE|IDBG-14629|ENSG00000108953|7531|; 
FBXW7 Mutants and NOTCH1 in Cancer	17874	REACTOME	9606	9	70	1.9768036646174313E-7	3.918307263795266E-6	EP300; HDAC3; NCOR1; NCOR2; TBL1X; TBL1XR1; TLE1; TLE2; UBC; 	EP300|IDBG-8992|ENSG00000100393|2033|; HDAC3|IDBG-50725|ENSG00000171720|8841|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Signaling by NOTCH1	19096	REACTOME	9606	9	70	1.9768036646174313E-7	3.918307263795266E-6	EP300; HDAC3; NCOR1; NCOR2; TBL1X; TBL1XR1; TLE1; TLE2; UBC; 	EP300|IDBG-8992|ENSG00000100393|2033|; HDAC3|IDBG-50725|ENSG00000171720|8841|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Signaling by NOTCH1 HD Domain Mutants in Cancer	19129	REACTOME	9606	9	70	1.9768036646174313E-7	3.918307263795266E-6	EP300; HDAC3; NCOR1; NCOR2; TBL1X; TBL1XR1; TLE1; TLE2; UBC; 	EP300|IDBG-8992|ENSG00000100393|2033|; HDAC3|IDBG-50725|ENSG00000171720|8841|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer	18776	REACTOME	9606	9	70	1.9768036646174313E-7	3.918307263795266E-6	EP300; HDAC3; NCOR1; NCOR2; TBL1X; TBL1XR1; TLE1; TLE2; UBC; 	EP300|IDBG-8992|ENSG00000100393|2033|; HDAC3|IDBG-50725|ENSG00000171720|8841|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Signaling by NOTCH1 PEST Domain Mutants in Cancer	18501	REACTOME	9606	9	70	1.9768036646174313E-7	3.918307263795266E-6	EP300; HDAC3; NCOR1; NCOR2; TBL1X; TBL1XR1; TLE1; TLE2; UBC; 	EP300|IDBG-8992|ENSG00000100393|2033|; HDAC3|IDBG-50725|ENSG00000171720|8841|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Signaling by NOTCH1 in Cancer	17392	REACTOME	9606	9	70	1.9768036646174313E-7	3.918307263795266E-6	EP300; HDAC3; NCOR1; NCOR2; TBL1X; TBL1XR1; TLE1; TLE2; UBC; 	EP300|IDBG-8992|ENSG00000100393|2033|; HDAC3|IDBG-50725|ENSG00000171720|8841|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	16917	REACTOME	9606	9	70	1.9768036646174313E-7	3.918307263795266E-6	EP300; HDAC3; NCOR1; NCOR2; TBL1X; TBL1XR1; TLE1; TLE2; UBC; 	EP300|IDBG-8992|ENSG00000100393|2033|; HDAC3|IDBG-50725|ENSG00000171720|8841|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
RNF mutants show enhanced WNT signaling and proliferation	19131	REACTOME	9606	14	197	1.571672450413167E-7	4.361391049896538E-6	AKT2; CHD8; CSNK1E; CSNK2A1; CUL3; EP300; HIST2H2AC; HIST2H2BE; HIST3H3; LRP5; LRP6; TLE1; TLE2; UBC; 	AKT2|IDBG-51270|ENSG00000105221|208|; CHD8|IDBG-2645|ENSG00000100888|57680|; CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; CSNK2A1|IDBG-37787|ENSG00000101266|1457|; CUL3|IDBG-82331|ENSG00000036257|8452|; EP300|IDBG-8992|ENSG00000100393|2033|; HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; LRP5|IDBG-61383|ENSG00000162337|4041|; LRP6|IDBG-20075|ENSG00000070018|4040|; TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
TCF dependent signaling in response to WNT	18732	REACTOME	9606	14	197	1.571672450413167E-7	4.361391049896538E-6	AKT2; CHD8; CSNK1E; CSNK2A1; CUL3; EP300; HIST2H2AC; HIST2H2BE; HIST3H3; LRP5; LRP6; TLE1; TLE2; UBC; 	AKT2|IDBG-51270|ENSG00000105221|208|; CHD8|IDBG-2645|ENSG00000100888|57680|; CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; CSNK2A1|IDBG-37787|ENSG00000101266|1457|; CUL3|IDBG-82331|ENSG00000036257|8452|; EP300|IDBG-8992|ENSG00000100393|2033|; HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; LRP5|IDBG-61383|ENSG00000162337|4041|; LRP6|IDBG-20075|ENSG00000070018|4040|; TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
XAV939 inhibits tankyrase, stabilizing AXIN	19487	REACTOME	9606	14	197	1.571672450413167E-7	4.361391049896538E-6	AKT2; CHD8; CSNK1E; CSNK2A1; CUL3; EP300; HIST2H2AC; HIST2H2BE; HIST3H3; LRP5; LRP6; TLE1; TLE2; UBC; 	AKT2|IDBG-51270|ENSG00000105221|208|; CHD8|IDBG-2645|ENSG00000100888|57680|; CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; CSNK2A1|IDBG-37787|ENSG00000101266|1457|; CUL3|IDBG-82331|ENSG00000036257|8452|; EP300|IDBG-8992|ENSG00000100393|2033|; HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; LRP5|IDBG-61383|ENSG00000162337|4041|; LRP6|IDBG-20075|ENSG00000070018|4040|; TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling	16943	REACTOME	9606	14	197	1.571672450413167E-7	4.361391049896538E-6	AKT2; CHD8; CSNK1E; CSNK2A1; CUL3; EP300; HIST2H2AC; HIST2H2BE; HIST3H3; LRP5; LRP6; TLE1; TLE2; UBC; 	AKT2|IDBG-51270|ENSG00000105221|208|; CHD8|IDBG-2645|ENSG00000100888|57680|; CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; CSNK2A1|IDBG-37787|ENSG00000101266|1457|; CUL3|IDBG-82331|ENSG00000036257|8452|; EP300|IDBG-8992|ENSG00000100393|2033|; HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; LRP5|IDBG-61383|ENSG00000162337|4041|; LRP6|IDBG-20075|ENSG00000070018|4040|; TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Wnt signaling pathway	445	KEGG	9606	12	140	1.6789802769512125E-7	4.4373050176567755E-6	CHD8; CSNK1E; CSNK2A1; DAAM2; EP300; LRP5; LRP6; MAP3K7; SMAD3; TBL1X; TBL1XR1; TBL1Y; 	CHD8|IDBG-2645|ENSG00000100888|57680|; CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; CSNK2A1|IDBG-37787|ENSG00000101266|1457|; DAAM2|IDBG-86252|ENSG00000146122|23500|; EP300|IDBG-8992|ENSG00000100393|2033|; LRP5|IDBG-61383|ENSG00000162337|4041|; LRP6|IDBG-20075|ENSG00000070018|4040|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; SMAD3|IDBG-18366|ENSG00000166949|4088|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; TBL1Y|IDBG-67|ENSG00000092377|90665|; 
Downregulation of SMAD2/3:SMAD4 transcriptional activity	13269	REACTOME	9606	6	23	2.945242359916653E-7	5.636584516392215E-6	NCOR1; NCOR2; PPM1A; SMAD2; SMAD3; UBC; 	NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; PPM1A|IDBG-8210|ENSG00000100614|5494|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; UBC|IDBG-64029|ENSG00000150991|7316|; 
BMAL1:CLOCK,NPAS2 activates circadian gene expression	13670	REACTOME	9606	7	37	3.128535509512354E-7	5.787790692597854E-6	CRY2; EP300; HDAC3; NCOA6; NCOR1; TBL1X; TBL1XR1; 	CRY2|IDBG-41167|ENSG00000121671|1408|; EP300|IDBG-8992|ENSG00000100393|2033|; HDAC3|IDBG-50725|ENSG00000171720|8841|; NCOA6|IDBG-68724|ENSG00000198646|23054|; NCOR1|IDBG-31971|ENSG00000141027|9611|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; 
REV-ERBA represses gene expression	13671	REACTOME	9606	6	24	3.88685671171183E-7	6.958727338709889E-6	EP300; HDAC3; NCOA6; NCOR1; TBL1X; TBL1XR1; 	EP300|IDBG-8992|ENSG00000100393|2033|; HDAC3|IDBG-50725|ENSG00000171720|8841|; NCOA6|IDBG-68724|ENSG00000198646|23054|; NCOR1|IDBG-31971|ENSG00000141027|9611|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; 
RORA activates circadian gene expression	13668	REACTOME	9606	6	25	5.062025101682739E-7	8.779449785731001E-6	EP300; HDAC3; NCOA6; NCOR1; TBL1X; TBL1XR1; 	EP300|IDBG-8992|ENSG00000100393|2033|; HDAC3|IDBG-50725|ENSG00000171720|8841|; NCOA6|IDBG-68724|ENSG00000198646|23054|; NCOR1|IDBG-31971|ENSG00000141027|9611|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; 
Signaling by WNT in cancer	17000	REACTOME	9606	14	219	5.761417036544789E-7	9.689655925098053E-6	AKT2; CHD8; CSNK1E; CSNK2A1; CUL3; EP300; HIST2H2AC; HIST2H2BE; HIST3H3; LRP5; LRP6; TLE1; TLE2; UBC; 	AKT2|IDBG-51270|ENSG00000105221|208|; CHD8|IDBG-2645|ENSG00000100888|57680|; CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; CSNK2A1|IDBG-37787|ENSG00000101266|1457|; CUL3|IDBG-82331|ENSG00000036257|8452|; EP300|IDBG-8992|ENSG00000100393|2033|; HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; LRP5|IDBG-61383|ENSG00000162337|4041|; LRP6|IDBG-20075|ENSG00000070018|4040|; TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	18119	REACTOME	9606	7	42	7.782899887926914E-7	1.2704439522939522E-5	NCOR1; NCOR2; PPM1A; SMAD2; SMAD3; SP1; UBC; 	NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; PPM1A|IDBG-8210|ENSG00000100614|5494|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SP1|IDBG-36616|ENSG00000185591|6667|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Chromosome Maintenance	17495	REACTOME	9606	9	84	9.65791647128369E-7	1.5314696118749852E-5	HIST2H2AC; HIST2H2BE; HIST3H3; PCNA; POT1; PRIM1; PRIM2; TERF1; TERF2IP; 	HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; PCNA|IDBG-50801|ENSG00000132646|5111|; POT1|IDBG-39151|ENSG00000128513|25913|; PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; TERF1|IDBG-25349|ENSG00000147601|7013|; TERF2IP|IDBG-42783|ENSG00000166848|54386|; 
Wnt signaling pathway	16165	INOH	9606	9	91	1.9102730895247935E-6	2.8654096342871903E-5	CSNK1E; EP300; LRP5; LRP6; MAP3K7; TLE1; TLE2; YWHAE; YWHAQ; 	CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; EP300|IDBG-8992|ENSG00000100393|2033|; LRP5|IDBG-61383|ENSG00000162337|4041|; LRP6|IDBG-20075|ENSG00000070018|4040|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; YWHAE|IDBG-14629|ENSG00000108953|7531|; YWHAQ|IDBG-27933|ENSG00000134308|10971|; 
Cell Cycle	18205	REACTOME	9606	21	523	1.8905270887190513E-6	2.9145625951085374E-5	CCNB2; CSNK1E; CSNK2A1; EP300; GMNN; HIST2H2AC; HIST2H2BE; HIST3H3; MCM2; MIS12; ODF2; PCNA; POT1; PRIM1; PRIM2; RAD51; TERF1; TERF2IP; TUBA4A; UBC; YWHAE; 	CCNB2|IDBG-14456|ENSG00000157456|9133|; CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; CSNK2A1|IDBG-37787|ENSG00000101266|1457|; EP300|IDBG-8992|ENSG00000100393|2033|; GMNN|IDBG-65780|ENSG00000112312|51053|; HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; MCM2|IDBG-54871|ENSG00000073111|4171|; MIS12|IDBG-21731|ENSG00000167842|79003|; ODF2|IDBG-88092|ENSG00000136811|4957|; PCNA|IDBG-50801|ENSG00000132646|5111|; POT1|IDBG-39151|ENSG00000128513|25913|; PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; RAD51|IDBG-6509|ENSG00000051180|5888|; TERF1|IDBG-25349|ENSG00000147601|7013|; TERF2IP|IDBG-42783|ENSG00000166848|54386|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; UBC|IDBG-64029|ENSG00000150991|7316|; YWHAE|IDBG-14629|ENSG00000108953|7531|; 
TGF_beta_Receptor	15911	NETPATH	9606	13	220	3.603258452477135E-6	5.26265379243371E-5	AR; CCNB2; EP300; ESR1; EWSR1; KPNB1; MAP3K7; PPM1A; SHC1; SMAD2; SMAD3; SP1; TAB1; 	AR|IDBG-73722|ENSG00000169083|367|; CCNB2|IDBG-14456|ENSG00000157456|9133|; EP300|IDBG-8992|ENSG00000100393|2033|; ESR1|IDBG-97997|ENSG00000091831|2099|; EWSR1|IDBG-3488|ENSG00000182944|2130|; KPNB1|IDBG-56053|ENSG00000108424|3837|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; PPM1A|IDBG-8210|ENSG00000100614|5494|; SHC1|IDBG-103007|ENSG00000160691|6464|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SP1|IDBG-36616|ENSG00000185591|6667|; TAB1|IDBG-8281|ENSG00000100324|10454|; 
Tgf beta signaling pathway	4035	PID BIOCARTA	9606	5	20	3.843105271157099E-6	5.332308563730475E-5	EP300; MAP3K7; SMAD2; SMAD3; TAB1; 	EP300|IDBG-8992|ENSG00000100393|2033|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; TAB1|IDBG-8281|ENSG00000100324|10454|; 
Signaling by Wnt	17272	REACTOME	9606	15	294	3.822130014516411E-6	5.439185020657969E-5	AKT2; CHD8; CSNK1E; CSNK2A1; CUL3; EP300; HIST2H2AC; HIST2H2BE; HIST3H3; LRP5; LRP6; MAP3K7; TLE1; TLE2; UBC; 	AKT2|IDBG-51270|ENSG00000105221|208|; CHD8|IDBG-2645|ENSG00000100888|57680|; CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; CSNK2A1|IDBG-37787|ENSG00000101266|1457|; CUL3|IDBG-82331|ENSG00000036257|8452|; EP300|IDBG-8992|ENSG00000100393|2033|; HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; LRP5|IDBG-61383|ENSG00000162337|4041|; LRP6|IDBG-20075|ENSG00000070018|4040|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Packaging Of Telomere Ends	12919	REACTOME	9606	6	35	4.186914928705594E-6	5.667653135199036E-5	HIST2H2AC; HIST2H2BE; HIST3H3; POT1; TERF1; TERF2IP; 	HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; POT1|IDBG-39151|ENSG00000128513|25913|; TERF1|IDBG-25349|ENSG00000147601|7013|; TERF2IP|IDBG-42783|ENSG00000166848|54386|; 
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants	13720	REACTOME	9606	7	56	5.785241411620379E-6	7.466997635928629E-5	EP300; HDAC3; NCOR1; NCOR2; TBL1X; TBL1XR1; UBC; 	EP300|IDBG-8992|ENSG00000100393|2033|; HDAC3|IDBG-50725|ENSG00000171720|8841|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Constitutive Signaling by NOTCH1 PEST Domain Mutants	13718	REACTOME	9606	7	56	5.785241411620379E-6	7.466997635928629E-5	EP300; HDAC3; NCOR1; NCOR2; TBL1X; TBL1XR1; UBC; 	EP300|IDBG-8992|ENSG00000100393|2033|; HDAC3|IDBG-50725|ENSG00000171720|8841|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Cellular Senescence	18630	REACTOME	9606	11	164	6.340088076384544E-6	7.99715655089414E-5	CBX2; HIST2H2AC; HIST2H2BE; HIST3H3; POT1; RNF2; SP1; SUZ12; TERF1; TERF2IP; UBC; 	CBX2|IDBG-71184|ENSG00000173894|84733|; HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; POT1|IDBG-39151|ENSG00000128513|25913|; RNF2|IDBG-105369|ENSG00000121481|6045|; SP1|IDBG-36616|ENSG00000185591|6667|; SUZ12|IDBG-39777|ENSG00000178691|23512|; TERF1|IDBG-25349|ENSG00000147601|7013|; TERF2IP|IDBG-42783|ENSG00000166848|54386|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Signaling by NOTCH	18790	REACTOME	9606	9	109	8.600029930478122E-6	1.0606703580923017E-4	EP300; HDAC3; NCOR1; NCOR2; TBL1X; TBL1XR1; TLE1; TLE2; UBC; 	EP300|IDBG-8992|ENSG00000100393|2033|; HDAC3|IDBG-50725|ENSG00000171720|8841|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Regulation of cytoplasmic and nuclear SMAD2/3 signaling	15659	PID NCI	9606	4	12	1.0860660699184175E-5	1.3103623234885254E-4	KPNB1; PPM1A; SMAD2; SMAD3; 	KPNB1|IDBG-56053|ENSG00000108424|3837|; PPM1A|IDBG-8210|ENSG00000100614|5494|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; 
Disease	19807	REACTOME	9606	32	1192	1.8620324366831874E-5	2.1987829837429127E-4	AKT2; APP; CHD8; CSNK1E; CSNK2A1; CUL3; EGFR; EP300; HDAC3; HIST2H2AC; HIST2H2BE; HIST3H3; HS2ST1; JAK2; KPNB1; LRP5; LRP6; NCOR1; NCOR2; PPM1A; PRPS1; RPS4Y1; SHC1; SMAD2; SMAD3; SP1; SV2B; TBL1X; TBL1XR1; TLE1; TLE2; UBC; 	AKT2|IDBG-51270|ENSG00000105221|208|; APP|IDBG-1100|ENSG00000142192|351|; CHD8|IDBG-2645|ENSG00000100888|57680|; CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; CSNK2A1|IDBG-37787|ENSG00000101266|1457|; CUL3|IDBG-82331|ENSG00000036257|8452|; EGFR|IDBG-16933|ENSG00000146648|1956|; EP300|IDBG-8992|ENSG00000100393|2033|; HDAC3|IDBG-50725|ENSG00000171720|8841|; HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; HS2ST1|IDBG-100108|ENSG00000153936|9653|; JAK2|IDBG-47039|ENSG00000096968|3717|; KPNB1|IDBG-56053|ENSG00000108424|3837|; LRP5|IDBG-61383|ENSG00000162337|4041|; LRP6|IDBG-20075|ENSG00000070018|4040|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; PPM1A|IDBG-8210|ENSG00000100614|5494|; PRPS1|IDBG-81487|ENSG00000147224|5631|; RPS4Y1|IDBG-6|ENSG00000129824|6192|; SHC1|IDBG-103007|ENSG00000160691|6464|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SP1|IDBG-36616|ENSG00000185591|6667|; SV2B|IDBG-30872|ENSG00000185518|9899|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Loss of Function of SMAD2/3 in Cancer	17055	REACTOME	9606	7	70	2.5862467630797106E-5	2.3151079895310312E-4	NCOR1; NCOR2; PPM1A; SMAD2; SMAD3; SP1; UBC; 	NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; PPM1A|IDBG-8210|ENSG00000100614|5494|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SP1|IDBG-36616|ENSG00000185591|6667|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Loss of Function of SMAD4 in Cancer	17027	REACTOME	9606	7	70	2.5862467630797106E-5	2.3151079895310312E-4	NCOR1; NCOR2; PPM1A; SMAD2; SMAD3; SP1; UBC; 	NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; PPM1A|IDBG-8210|ENSG00000100614|5494|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SP1|IDBG-36616|ENSG00000185591|6667|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Loss of Function of TGFBR1 in Cancer	19193	REACTOME	9606	7	70	2.5862467630797106E-5	2.3151079895310312E-4	NCOR1; NCOR2; PPM1A; SMAD2; SMAD3; SP1; UBC; 	NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; PPM1A|IDBG-8210|ENSG00000100614|5494|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SP1|IDBG-36616|ENSG00000185591|6667|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Loss of Function of TGFBR2 in Cancer	18204	REACTOME	9606	7	70	2.5862467630797106E-5	2.3151079895310312E-4	NCOR1; NCOR2; PPM1A; SMAD2; SMAD3; SP1; UBC; 	NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; PPM1A|IDBG-8210|ENSG00000100614|5494|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SP1|IDBG-36616|ENSG00000185591|6667|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Regulation of nuclear SMAD2/3 signaling	15480	PID NCI	9606	7	70	2.5862467630797106E-5	2.3151079895310312E-4	AR; EP300; ESR1; NCOR1; SMAD2; SMAD3; SP1; 	AR|IDBG-73722|ENSG00000169083|367|; EP300|IDBG-8992|ENSG00000100393|2033|; ESR1|IDBG-97997|ENSG00000091831|2099|; NCOR1|IDBG-31971|ENSG00000141027|9611|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SP1|IDBG-36616|ENSG00000185591|6667|; 
SMAD2/3 MH2 Domain Mutants in Cancer	18188	REACTOME	9606	7	70	2.5862467630797106E-5	2.3151079895310312E-4	NCOR1; NCOR2; PPM1A; SMAD2; SMAD3; SP1; UBC; 	NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; PPM1A|IDBG-8210|ENSG00000100614|5494|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SP1|IDBG-36616|ENSG00000185591|6667|; UBC|IDBG-64029|ENSG00000150991|7316|; 
SMAD2/3 Phosphorylation Motif Mutants in Cancer	18488	REACTOME	9606	7	70	2.5862467630797106E-5	2.3151079895310312E-4	NCOR1; NCOR2; PPM1A; SMAD2; SMAD3; SP1; UBC; 	NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; PPM1A|IDBG-8210|ENSG00000100614|5494|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SP1|IDBG-36616|ENSG00000185591|6667|; UBC|IDBG-64029|ENSG00000150991|7316|; 
SMAD4 MH2 Domain Mutants in Cancer	16763	REACTOME	9606	7	70	2.5862467630797106E-5	2.3151079895310312E-4	NCOR1; NCOR2; PPM1A; SMAD2; SMAD3; SP1; UBC; 	NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; PPM1A|IDBG-8210|ENSG00000100614|5494|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SP1|IDBG-36616|ENSG00000185591|6667|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Signaling by TGF-beta Receptor Complex	19869	REACTOME	9606	7	70	2.5862467630797106E-5	2.3151079895310312E-4	NCOR1; NCOR2; PPM1A; SMAD2; SMAD3; SP1; UBC; 	NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; PPM1A|IDBG-8210|ENSG00000100614|5494|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SP1|IDBG-36616|ENSG00000185591|6667|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Signaling by TGF-beta Receptor Complex in Cancer	17260	REACTOME	9606	7	70	2.5862467630797106E-5	2.3151079895310312E-4	NCOR1; NCOR2; PPM1A; SMAD2; SMAD3; SP1; UBC; 	NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; PPM1A|IDBG-8210|ENSG00000100614|5494|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SP1|IDBG-36616|ENSG00000185591|6667|; UBC|IDBG-64029|ENSG00000150991|7316|; 
TGFBR1 KD Mutants in Cancer	18966	REACTOME	9606	7	70	2.5862467630797106E-5	2.3151079895310312E-4	NCOR1; NCOR2; PPM1A; SMAD2; SMAD3; SP1; UBC; 	NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; PPM1A|IDBG-8210|ENSG00000100614|5494|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SP1|IDBG-36616|ENSG00000185591|6667|; UBC|IDBG-64029|ENSG00000150991|7316|; 
TGFBR1 LBD Mutants in Cancer	19248	REACTOME	9606	7	70	2.5862467630797106E-5	2.3151079895310312E-4	NCOR1; NCOR2; PPM1A; SMAD2; SMAD3; SP1; UBC; 	NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; PPM1A|IDBG-8210|ENSG00000100614|5494|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SP1|IDBG-36616|ENSG00000185591|6667|; UBC|IDBG-64029|ENSG00000150991|7316|; 
TGFBR2 Kinase Domain Mutants in Cancer	19454	REACTOME	9606	7	70	2.5862467630797106E-5	2.3151079895310312E-4	NCOR1; NCOR2; PPM1A; SMAD2; SMAD3; SP1; UBC; 	NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; PPM1A|IDBG-8210|ENSG00000100614|5494|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SP1|IDBG-36616|ENSG00000185591|6667|; UBC|IDBG-64029|ENSG00000150991|7316|; 
TGFBR2 MSI Frameshift Mutants in Cancer	17966	REACTOME	9606	7	70	2.5862467630797106E-5	2.3151079895310312E-4	NCOR1; NCOR2; PPM1A; SMAD2; SMAD3; SP1; UBC; 	NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; PPM1A|IDBG-8210|ENSG00000100614|5494|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SP1|IDBG-36616|ENSG00000185591|6667|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Role of erbb2 in signal transduction and oncology	4019	PID BIOCARTA	9606	5	28	2.2478560715984532E-5	2.5990835827857114E-4	EGFR; EP300; ESR1; JAK2; SHC1; 	EGFR|IDBG-16933|ENSG00000146648|1956|; EP300|IDBG-8992|ENSG00000100393|2033|; ESR1|IDBG-97997|ENSG00000091831|2099|; JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Regulation of nuclear beta catenin signaling and target gene transcription	15295	PID NCI	9606	7	72	3.1129098306698034E-5	2.7423253270186364E-4	AR; CHD8; EP300; TBL1X; TBL1XR1; TLE1; TLE2; 	AR|IDBG-73722|ENSG00000169083|367|; CHD8|IDBG-2645|ENSG00000100888|57680|; EP300|IDBG-8992|ENSG00000100393|2033|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; 
Wnt signaling pathway	4172	PID BIOCARTA	9606	5	30	3.1945684693876594E-5	2.770289844547111E-4	CSNK2A1; LRP6; MAP3K7; TAB1; TLE1; 	CSNK2A1|IDBG-37787|ENSG00000101266|1457|; LRP6|IDBG-20075|ENSG00000070018|4040|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; TLE1|IDBG-73128|ENSG00000196781|7088|; 
Alpha6Beta4Integrin	15905	NETPATH	9606	7	74	3.7248025243206796E-5	3.180408309227657E-4	AR; EGFR; SHC1; SMAD2; SMAD3; YWHAE; YWHAQ; 	AR|IDBG-73722|ENSG00000169083|367|; EGFR|IDBG-16933|ENSG00000146648|1956|; SHC1|IDBG-103007|ENSG00000160691|6464|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; YWHAE|IDBG-14629|ENSG00000108953|7531|; YWHAQ|IDBG-27933|ENSG00000134308|10971|; 
Transcriptional regulation of white adipocyte differentiation	13879	REACTOME	9606	7	77	4.82522436562781E-5	4.0575750347324766E-4	EP300; HDAC3; NCOA6; NCOR1; NCOR2; TBL1X; TBL1XR1; 	EP300|IDBG-8992|ENSG00000100393|2033|; HDAC3|IDBG-50725|ENSG00000171720|8841|; NCOA6|IDBG-68724|ENSG00000198646|23054|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; 
Cell Cycle, Mitotic	19119	REACTOME	9606	17	454	4.9198472274301E-5	4.0753958376473214E-4	CCNB2; CSNK1E; CSNK2A1; EP300; GMNN; HIST2H2AC; HIST2H2BE; HIST3H3; MCM2; MIS12; ODF2; PCNA; PRIM1; PRIM2; TUBA4A; UBC; YWHAE; 	CCNB2|IDBG-14456|ENSG00000157456|9133|; CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; CSNK2A1|IDBG-37787|ENSG00000101266|1457|; EP300|IDBG-8992|ENSG00000100393|2033|; GMNN|IDBG-65780|ENSG00000112312|51053|; HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; MCM2|IDBG-54871|ENSG00000073111|4171|; MIS12|IDBG-21731|ENSG00000167842|79003|; ODF2|IDBG-88092|ENSG00000136811|4957|; PCNA|IDBG-50801|ENSG00000132646|5111|; PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; UBC|IDBG-64029|ENSG00000150991|7316|; YWHAE|IDBG-14629|ENSG00000108953|7531|; 
deactivation of the beta-catenin transactivating complex	17798	REACTOME	9606	5	33	5.1625401300095606E-5	4.213543782581333E-4	AKT2; CHD8; TLE1; TLE2; UBC; 	AKT2|IDBG-51270|ENSG00000105221|208|; CHD8|IDBG-2645|ENSG00000100888|57680|; TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)	13458	REACTOME	9606	8	109	6.492040136575114E-5	5.22185837072346E-4	EP300; HDAC3; NCOA6; NCOR1; NCOR2; SP1; TBL1X; TBL1XR1; 	EP300|IDBG-8992|ENSG00000100393|2033|; HDAC3|IDBG-50725|ENSG00000171720|8841|; NCOA6|IDBG-68724|ENSG00000198646|23054|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; SP1|IDBG-36616|ENSG00000185591|6667|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; 
Meiotic synapsis	12911	REACTOME	9606	6	59	9.090434565109959E-5	7.207415976622897E-4	HIST2H2AC; HIST2H2BE; HIST3H3; POT1; TERF1; TERF2IP; 	HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; POT1|IDBG-39151|ENSG00000128513|25913|; TERF1|IDBG-25349|ENSG00000147601|7013|; TERF2IP|IDBG-42783|ENSG00000166848|54386|; 
DNA Damage/Telomere Stress Induced Senescence	18208	REACTOME	9606	6	62	1.2028199005940387E-4	9.402324575066076E-4	HIST2H2AC; HIST2H2BE; HIST3H3; POT1; TERF1; TERF2IP; 	HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; POT1|IDBG-39151|ENSG00000128513|25913|; TERF1|IDBG-25349|ENSG00000147601|7013|; TERF2IP|IDBG-42783|ENSG00000166848|54386|; 
TGF-beta signaling	16255	INOH	9606	8	120	1.2801848214188477E-4	9.868091331770284E-4	EP300; HDAC3; MAP3K7; SMAD2; SMAD3; TAB1; TLE1; TLE2; 	EP300|IDBG-8992|ENSG00000100393|2033|; HDAC3|IDBG-50725|ENSG00000171720|8841|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; TAB1|IDBG-8281|ENSG00000100324|10454|; TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; 
TNFalpha	15913	NETPATH	9606	12	270	1.427187619754882E-4	0.0010850536013204924	AKT2; CSNK2A1; EGFR; EP300; HIST3H3; MAP3K7; SMAD2; SMAD3; SMARCB1; TAB1; YWHAE; YWHAQ; 	AKT2|IDBG-51270|ENSG00000105221|208|; CSNK2A1|IDBG-37787|ENSG00000101266|1457|; EGFR|IDBG-16933|ENSG00000146648|1956|; EP300|IDBG-8992|ENSG00000100393|2033|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SMARCB1|IDBG-2584|ENSG00000099956|6598|; TAB1|IDBG-8281|ENSG00000100324|10454|; YWHAE|IDBG-14629|ENSG00000108953|7531|; YWHAQ|IDBG-27933|ENSG00000134308|10971|; 
Meiosis	19435	REACTOME	9606	7	92	1.5050657650196255E-4	0.0011287993237647192	HIST2H2AC; HIST2H2BE; HIST3H3; POT1; RAD51; TERF1; TERF2IP; 	HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; POT1|IDBG-39151|ENSG00000128513|25913|; RAD51|IDBG-6509|ENSG00000051180|5888|; TERF1|IDBG-25349|ENSG00000147601|7013|; TERF2IP|IDBG-42783|ENSG00000166848|54386|; 
formation of the beta-catenin:TCF transactivating complex	19208	REACTOME	9606	6	66	1.7066019325880034E-4	0.001246268516560976	EP300; HIST2H2AC; HIST2H2BE; HIST3H3; TLE1; TLE2; 	EP300|IDBG-8992|ENSG00000100393|2033|; HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; 
Developmental Biology	16794	REACTOME	9606	17	502	1.6866976622123938E-4	0.0012481562700371715	AKT2; CACNB3; CSNK2A1; DPYSL2; DPYSL5; EGFR; EP300; HDAC3; JAK2; NCOA6; NCOR1; NCOR2; SMAD2; SMAD3; TBL1X; TBL1XR1; TUBA4A; 	AKT2|IDBG-51270|ENSG00000105221|208|; CACNB3|IDBG-30418|ENSG00000167535|784|; CSNK2A1|IDBG-37787|ENSG00000101266|1457|; DPYSL2|IDBG-13200|ENSG00000092964|102723812,1808|; DPYSL5|IDBG-36183|ENSG00000157851|56896|; EGFR|IDBG-16933|ENSG00000146648|1956|; EP300|IDBG-8992|ENSG00000100393|2033|; HDAC3|IDBG-50725|ENSG00000171720|8841|; JAK2|IDBG-47039|ENSG00000096968|3717|; NCOA6|IDBG-68724|ENSG00000198646|23054|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; 
Cell cycle	473	KEGG	9606	8	126	1.7974117952844989E-4	0.0012955370732245415	CCNB2; EP300; MCM2; PCNA; SMAD2; SMAD3; YWHAE; YWHAQ; 	CCNB2|IDBG-14456|ENSG00000157456|9133|; EP300|IDBG-8992|ENSG00000100393|2033|; MCM2|IDBG-54871|ENSG00000073111|4171|; PCNA|IDBG-50801|ENSG00000132646|5111|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; YWHAE|IDBG-14629|ENSG00000108953|7531|; YWHAQ|IDBG-27933|ENSG00000134308|10971|; 
Pancreatic cancer	593	KEGG	9606	6	67	1.8554272579268864E-4	0.001320207856601823	AKT2; EGFR; RAD51; RALB; SMAD2; SMAD3; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; RAD51|IDBG-6509|ENSG00000051180|5888|; RALB|IDBG-68212|ENSG00000144118|5899|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; 
Leptin	15926	NETPATH	9606	7	96	1.9647724168200055E-4	0.0013803147991583583	CSNK2A1; EGFR; EP300; ESR1; JAK2; SHC1; SP1; 	CSNK2A1|IDBG-37787|ENSG00000101266|1457|; EGFR|IDBG-16933|ENSG00000146648|1956|; EP300|IDBG-8992|ENSG00000100393|2033|; ESR1|IDBG-97997|ENSG00000091831|2099|; JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; SP1|IDBG-36616|ENSG00000185591|6667|; 
Transcriptional activation of mitochondrial biogenesis	18752	REACTOME	9606	5	44	2.115685896702754E-4	0.0014677570908375355	HDAC3; NCOA6; NCOR1; TBL1X; TBL1XR1; 	HDAC3|IDBG-50725|ENSG00000171720|8841|; NCOA6|IDBG-68724|ENSG00000198646|23054|; NCOR1|IDBG-31971|ENSG00000141027|9611|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; 
IRAK2 mediated activation of TAK1 complex	13033	REACTOME	9606	3	10	2.1773116519184185E-4	0.001473668252213076	MAP3K7; TAB1; UBC; 	MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; UBC|IDBG-64029|ENSG00000150991|7316|; 
IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation	13038	REACTOME	9606	3	10	2.1773116519184185E-4	0.001473668252213076	MAP3K7; TAB1; UBC; 	MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Presenilin action in Notch and Wnt signaling	15094	PID NCI	9606	5	46	2.6174892889767955E-4	0.0017502488619061704	CSNK2A1; LRP6; MAP3K7; TAB1; TLE1; 	CSNK2A1|IDBG-37787|ENSG00000101266|1457|; LRP6|IDBG-20075|ENSG00000070018|4040|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; TLE1|IDBG-73128|ENSG00000196781|7088|; 
TGF-beta receptor signaling	15571	PID NCI	9606	5	47	2.8999373415916174E-4	0.00191603002926589	MAP3K7; SHC1; SMAD2; SMAD3; YWHAE; 	MAP3K7|IDBG-94374|ENSG00000135341|6885|; SHC1|IDBG-103007|ENSG00000160691|6464|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; YWHAE|IDBG-14629|ENSG00000108953|7531|; 
Adherens junction	505	KEGG	9606	6	73	2.977039986464423E-4	0.0019438319911620643	CSNK2A1; EGFR; EP300; MAP3K7; SMAD2; SMAD3; 	CSNK2A1|IDBG-37787|ENSG00000101266|1457|; EGFR|IDBG-16933|ENSG00000146648|1956|; EP300|IDBG-8992|ENSG00000100393|2033|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; 
Signaling by ERBB4	13265	REACTOME	9606	8	137	3.189514499434051E-4	0.002058349473471975	AKT2; EGFR; ESR1; JAK2; NCOR1; SHC1; UBC; WWOX; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; ESR1|IDBG-97997|ENSG00000091831|2099|; JAK2|IDBG-47039|ENSG00000096968|3717|; NCOR1|IDBG-31971|ENSG00000141027|9611|; SHC1|IDBG-103007|ENSG00000160691|6464|; UBC|IDBG-64029|ENSG00000150991|7316|; WWOX|IDBG-43129|ENSG00000186153|51741|; 
p73 transcription factor network	15377	PID NCI	9606	6	75	3.450355302863881E-4	0.0022010887276890274	AEN; EP300; RAD51; SIRT1; SP1; WWOX; 	AEN|IDBG-28670|ENSG00000181026|64782|; EP300|IDBG-8992|ENSG00000100393|2033|; RAD51|IDBG-6509|ENSG00000051180|5888|; SIRT1|IDBG-75847|ENSG00000096717|23411|; SP1|IDBG-36616|ENSG00000185591|6667|; WWOX|IDBG-43129|ENSG00000186153|51741|; 
Notch	15907	NETPATH	9606	6	76	3.708109455966518E-4	0.0023386372137061563	APP; EP300; JAK2; NCOR1; NCOR2; SMAD3; 	APP|IDBG-1100|ENSG00000142192|351|; EP300|IDBG-8992|ENSG00000100393|2033|; JAK2|IDBG-47039|ENSG00000096968|3717|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; SMAD3|IDBG-18366|ENSG00000166949|4088|; 
Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	18305	REACTOME	9606	5	50	3.887172524233749E-4	0.0023449790771192724	APP; CYLD; MAP3K7; TAB1; UBC; 	APP|IDBG-1100|ENSG00000142192|351|; CYLD|IDBG-30697|ENSG00000083799|102724054,1540|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Regulation of cholesterol biosynthesis by SREBP (SREBF)	13470	REACTOME	9606	5	50	3.887172524233749E-4	0.0023449790771192724	KPNB1; NCOA6; SP1; TBL1X; TBL1XR1; 	KPNB1|IDBG-56053|ENSG00000108424|3837|; NCOA6|IDBG-68724|ENSG00000198646|23054|; SP1|IDBG-36616|ENSG00000185591|6667|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; 
Signaling events mediated by HDAC Class I	15280	PID NCI	9606	5	50	3.887172524233749E-4	0.0023449790771192724	CHD3; CHD4; HDAC3; NCOR1; NCOR2; 	CHD3|IDBG-27053|ENSG00000170004|1107|; CHD4|IDBG-14532|ENSG00000111642|1108|; HDAC3|IDBG-50725|ENSG00000171720|8841|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; 
PPARA activates gene expression	13457	REACTOME	9606	7	107	3.8367333782483837E-4	0.002392569690930172	EP300; HDAC3; NCOA6; NCOR1; SP1; TBL1X; TBL1XR1; 	EP300|IDBG-8992|ENSG00000100393|2033|; HDAC3|IDBG-50725|ENSG00000171720|8841|; NCOA6|IDBG-68724|ENSG00000198646|23054|; NCOR1|IDBG-31971|ENSG00000141027|9611|; SP1|IDBG-36616|ENSG00000185591|6667|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; 
Regulation of PLK1 Activity at G2/M Transition	12974	REACTOME	9606	6	78	4.2686993148383686E-4	0.00254744959111322	CCNB2; CSNK1E; ODF2; TUBA4A; UBC; YWHAE; 	CCNB2|IDBG-14456|ENSG00000157456|9133|; CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; ODF2|IDBG-88092|ENSG00000136811|4957|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; UBC|IDBG-64029|ENSG00000150991|7316|; YWHAE|IDBG-14629|ENSG00000108953|7531|; 
ErbB4 signaling events	15100	PID NCI	9606	4	30	5.047962029877919E-4	0.002918353048523172	JAK2; NCOR1; SHC1; WWOX; 	JAK2|IDBG-47039|ENSG00000096968|3717|; NCOR1|IDBG-31971|ENSG00000141027|9611|; SHC1|IDBG-103007|ENSG00000160691|6464|; WWOX|IDBG-43129|ENSG00000186153|51741|; 
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription	13270	REACTOME	9606	4	30	5.047962029877919E-4	0.002918353048523172	SMAD2; SMAD3; SP1; UBC; 	SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SP1|IDBG-36616|ENSG00000185591|6667|; UBC|IDBG-64029|ENSG00000150991|7316|; 
TAK1 activates NFkB by phosphorylation and activation of IKKs complex	13027	REACTOME	9606	4	30	5.047962029877919E-4	0.002918353048523172	APP; MAP3K7; TAB1; UBC; 	APP|IDBG-1100|ENSG00000142192|351|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Mitochondrial biogenesis	17433	REACTOME	9606	5	53	5.109366596425526E-4	0.0029234004752743993	HDAC3; NCOA6; NCOR1; TBL1X; TBL1XR1; 	HDAC3|IDBG-50725|ENSG00000171720|8841|; NCOA6|IDBG-68724|ENSG00000198646|23054|; NCOR1|IDBG-31971|ENSG00000141027|9611|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; 
Generic Transcription Pathway	13742	REACTOME	9606	15	458	5.959041269145937E-4	0.0033747631677306074	AR; ESR1; NCOA6; NCOR1; NCOR2; PPM1A; SMAD2; SMAD3; SP1; TBL1X; TBL1XR1; UBC; ZNF317; ZNF331; ZNF746; 	AR|IDBG-73722|ENSG00000169083|367|; ESR1|IDBG-97997|ENSG00000091831|2099|; NCOA6|IDBG-68724|ENSG00000198646|23054|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; PPM1A|IDBG-8210|ENSG00000100614|5494|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SP1|IDBG-36616|ENSG00000185591|6667|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; UBC|IDBG-64029|ENSG00000150991|7316|; ZNF317|IDBG-25519|ENSG00000130803|57693|; ZNF331|IDBG-67685|ENSG00000130844|55422|; ZNF746|IDBG-47452|ENSG00000181220|155061|; 
Circadian rhythm pathway	15497	PID NCI	9606	3	14	6.366069362349099E-4	0.003430260675828883	CRY2; CSNK1E; WDR5; 	CRY2|IDBG-41167|ENSG00000121671|1408|; CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; WDR5|IDBG-91736|ENSG00000196363|11091|; 
Leading Strand Synthesis	12953	REACTOME	9606	3	14	6.366069362349099E-4	0.003430260675828883	PCNA; PRIM1; PRIM2; 	PCNA|IDBG-50801|ENSG00000132646|5111|; PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; 
Polymerase switching	12951	REACTOME	9606	3	14	6.366069362349099E-4	0.003430260675828883	PCNA; PRIM1; PRIM2; 	PCNA|IDBG-50801|ENSG00000132646|5111|; PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; 
Polymerase switching on the C-strand of the telomere	12914	REACTOME	9606	3	14	6.366069362349099E-4	0.003430260675828883	PCNA; PRIM1; PRIM2; 	PCNA|IDBG-50801|ENSG00000132646|5111|; PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; 
Removal of the Flap Intermediate	12949	REACTOME	9606	3	14	6.366069362349099E-4	0.003430260675828883	PCNA; PRIM1; PRIM2; 	PCNA|IDBG-50801|ENSG00000132646|5111|; PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; 
DNA strand elongation	19139	REACTOME	9606	4	32	6.496728250317953E-4	0.003467004018198523	MCM2; PCNA; PRIM1; PRIM2; 	MCM2|IDBG-54871|ENSG00000073111|4171|; PCNA|IDBG-50801|ENSG00000132646|5111|; PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; 
G2/M Transition	18803	REACTOME	9606	7	120	7.65442939386267E-4	0.004045912679613126	CCNB2; CSNK1E; EP300; ODF2; TUBA4A; UBC; YWHAE; 	CCNB2|IDBG-14456|ENSG00000157456|9133|; CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; EP300|IDBG-8992|ENSG00000100393|2033|; ODF2|IDBG-88092|ENSG00000136811|4957|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; UBC|IDBG-64029|ENSG00000150991|7316|; YWHAE|IDBG-14629|ENSG00000108953|7531|; 
Activation of BAD and translocation to mitochondria 	13399	REACTOME	9606	3	15	7.884870607703801E-4	0.0040898160628744015	AKT2; YWHAE; YWHAQ; 	AKT2|IDBG-51270|ENSG00000105221|208|; YWHAE|IDBG-14629|ENSG00000108953|7531|; YWHAQ|IDBG-27933|ENSG00000134308|10971|; 
TRAF6 mediated induction of TAK1 complex	13025	REACTOME	9606	3	15	7.884870607703801E-4	0.0040898160628744015	MAP3K7; TAB1; UBC; 	MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Signaling events mediated by HDAC Class II	15366	PID NCI	9606	4	34	8.217941367946358E-4	0.004223108758527989	ESR1; HDAC3; NCOR2; YWHAE; 	ESR1|IDBG-97997|ENSG00000091831|2099|; HDAC3|IDBG-50725|ENSG00000171720|8841|; NCOR2|IDBG-63911|ENSG00000196498|9612|; YWHAE|IDBG-14629|ENSG00000108953|7531|; 
Mitotic G2-G2/M phases	19400	REACTOME	9606	7	122	8.443145738900905E-4	0.004299032922100919	CCNB2; CSNK1E; EP300; ODF2; TUBA4A; UBC; YWHAE; 	CCNB2|IDBG-14456|ENSG00000157456|9133|; CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; EP300|IDBG-8992|ENSG00000100393|2033|; ODF2|IDBG-88092|ENSG00000136811|4957|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; UBC|IDBG-64029|ENSG00000150991|7316|; YWHAE|IDBG-14629|ENSG00000108953|7531|; 
NOD1/2 Signaling Pathway	13056	REACTOME	9606	4	35	9.1890160968248E-4	0.004636276303397968	CYLD; MAP3K7; TAB1; UBC; 	CYLD|IDBG-30697|ENSG00000083799|102724054,1540|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Processive synthesis on the lagging strand	12950	REACTOME	9606	3	16	9.615826497002494E-4	0.004807913248501247	PCNA; PRIM1; PRIM2; 	PCNA|IDBG-50801|ENSG00000132646|5111|; PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; 
FOXA1 transcription factor network	15723	PID NCI	9606	4	36	0.001023817783369076	0.005073382765802118	AR; ESR1; FOXA1; SP1; 	AR|IDBG-73722|ENSG00000169083|367|; ESR1|IDBG-97997|ENSG00000091831|2099|; FOXA1|IDBG-5104|ENSG00000129514|3169|; SP1|IDBG-36616|ENSG00000185591|6667|; 
Activation of gene expression by SREBF (SREBP)	13469	REACTOME	9606	4	37	0.0011368760104478513	0.005486662485204848	NCOA6; SP1; TBL1X; TBL1XR1; 	NCOA6|IDBG-68724|ENSG00000198646|23054|; SP1|IDBG-36616|ENSG00000185591|6667|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; 
DNA replication	441	KEGG	9606	4	37	0.0011368760104478513	0.005486662485204848	MCM2; PCNA; PRIM1; PRIM2; 	MCM2|IDBG-54871|ENSG00000073111|4171|; PCNA|IDBG-50801|ENSG00000132646|5111|; PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; 
Nuclear signaling by ERBB4	13262	REACTOME	9606	4	37	0.0011368760104478513	0.005486662485204848	ESR1; JAK2; NCOR1; WWOX; 	ESR1|IDBG-97997|ENSG00000091831|2099|; JAK2|IDBG-47039|ENSG00000096968|3717|; NCOR1|IDBG-31971|ENSG00000141027|9611|; WWOX|IDBG-43129|ENSG00000186153|51741|; 
Map kinase inactivation of smrt corepressor	4027	PID BIOCARTA	9606	3	17	0.0011569781399453241	0.005535541962669439	EGFR; NCOR2; SHC1; 	EGFR|IDBG-16933|ENSG00000146648|1956|; NCOR2|IDBG-63911|ENSG00000196498|9612|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
BMP2 signaling	16264	INOH	9606	5	64	0.001216433821539506	0.005721362465715474	EP300; MAP3K7; SMAD2; SMAD3; TAB1; 	EP300|IDBG-8992|ENSG00000100393|2033|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; TAB1|IDBG-8281|ENSG00000100324|10454|; 
Validated nuclear estrogen receptor alpha network	15063	PID NCI	9606	5	64	0.001216433821539506	0.005721362465715474	EP300; ESR1; NCOR1; NCOR2; PCNA; 	EP300|IDBG-8992|ENSG00000100393|2033|; ESR1|IDBG-97997|ENSG00000091831|2099|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; PCNA|IDBG-50801|ENSG00000132646|5111|; 
Cellular response to heat stress	18841	REACTOME	9606	4	38	0.0012584093930386128	0.005869052211230505	DNAJB1; EP300; SIRT1; YWHAE; 	DNAJB1|IDBG-33491|ENSG00000132002|3337|; EP300|IDBG-8992|ENSG00000100393|2033|; SIRT1|IDBG-75847|ENSG00000096717|23411|; YWHAE|IDBG-14629|ENSG00000108953|7531|; 
Gene Expression	19770	REACTOME	9606	26	1118	0.0012816597851009423	0.005927676506091858	AR; CHD3; CHD4; EIF1AX; ESR1; HIST2H2AC; HIST2H2BE; HNRNPF; HNRNPK; NCOA6; NCOR1; NCOR2; PPM1A; RBMX; RPS4Y1; SIRT1; SMAD2; SMAD3; SP1; SUZ12; TBL1X; TBL1XR1; UBC; ZNF317; ZNF331; ZNF746; 	AR|IDBG-73722|ENSG00000169083|367|; CHD3|IDBG-27053|ENSG00000170004|1107|; CHD4|IDBG-14532|ENSG00000111642|1108|; EIF1AX|IDBG-50658|ENSG00000173674|1964|; ESR1|IDBG-97997|ENSG00000091831|2099|; HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; HNRNPF|IDBG-71348|ENSG00000169813|3185|; HNRNPK|IDBG-73948|ENSG00000165119|3190|; NCOA6|IDBG-68724|ENSG00000198646|23054|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; PPM1A|IDBG-8210|ENSG00000100614|5494|; RBMX|IDBG-87732|ENSG00000147274|101928747,26787,27316|; RPS4Y1|IDBG-6|ENSG00000129824|6192|; SIRT1|IDBG-75847|ENSG00000096717|23411|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SP1|IDBG-36616|ENSG00000185591|6667|; SUZ12|IDBG-39777|ENSG00000178691|23512|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; UBC|IDBG-64029|ENSG00000150991|7316|; ZNF317|IDBG-25519|ENSG00000130803|57693|; ZNF331|IDBG-67685|ENSG00000130844|55422|; ZNF746|IDBG-47452|ENSG00000181220|155061|; 
Oxidative Stress Induced Senescence	19575	REACTOME	9606	6	97	0.001353650517435005	0.0062088928692266765	CBX2; HIST2H2AC; HIST2H2BE; RNF2; SUZ12; UBC; 	CBX2|IDBG-71184|ENSG00000173894|84733|; HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; RNF2|IDBG-105369|ENSG00000121481|6045|; SUZ12|IDBG-39777|ENSG00000178691|23512|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Signaling by constitutively active EGFR	13690	REACTOME	9606	3	18	0.001375708075485194	0.006258344113887563	EGFR; SHC1; UBC; 	EGFR|IDBG-16933|ENSG00000146648|1956|; SHC1|IDBG-103007|ENSG00000160691|6464|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Acetylation and deacetylation of rela in nucleus	4016	PID BIOCARTA	9606	2	5	0.0015275291473540963	0.006836924812754221	EP300; HDAC3; 	EP300|IDBG-8992|ENSG00000100393|2033|; HDAC3|IDBG-50725|ENSG00000171720|8841|; 
Pelp1 modulation of estrogen receptor activity	3957	PID BIOCARTA	9606	2	5	0.0015275291473540963	0.006836924812754221	EP300; ESR1; 	EP300|IDBG-8992|ENSG00000100393|2033|; ESR1|IDBG-97997|ENSG00000091831|2099|; 
Fatty acid, triacylglycerol, and ketone body metabolism	13534	REACTOME	9606	8	176	0.0016529738933628228	0.007339204086530934	EP300; HDAC3; NCOA6; NCOR1; NCOR2; SP1; TBL1X; TBL1XR1; 	EP300|IDBG-8992|ENSG00000100393|2033|; HDAC3|IDBG-50725|ENSG00000171720|8841|; NCOA6|IDBG-68724|ENSG00000198646|23054|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; SP1|IDBG-36616|ENSG00000185591|6667|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; 
Mechanism of gene regulation by peroxisome proliferators via ppara	3965	PID BIOCARTA	9606	4	41	0.0016771805240143373	0.007387580879586963	EP300; NCOR1; NCOR2; SP1; 	EP300|IDBG-8992|ENSG00000100393|2033|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; SP1|IDBG-36616|ENSG00000185591|6667|; 
JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1	13023	REACTOME	9606	3	20	0.0018870677471236924	0.00811877984227635	MAP3K7; TAB1; UBC; 	MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Regulation of HSF1-mediated heat shock response	17076	REACTOME	9606	3	20	0.0018870677471236924	0.00811877984227635	DNAJB1; SIRT1; YWHAE; 	DNAJB1|IDBG-33491|ENSG00000132002|3337|; SIRT1|IDBG-75847|ENSG00000096717|23411|; YWHAE|IDBG-14629|ENSG00000108953|7531|; 
SHC1 events in EGFR signaling	13213	REACTOME	9606	3	20	0.0018870677471236924	0.00811877984227635	EGFR; JAK2; SHC1; 	EGFR|IDBG-16933|ENSG00000146648|1956|; JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Notch-mediated HES/HEY network	15284	PID NCI	9606	4	43	0.0020048019956917205	0.008558962366222346	AR; EP300; JAK2; TLE1; 	AR|IDBG-73722|ENSG00000169083|367|; EP300|IDBG-8992|ENSG00000100393|2033|; JAK2|IDBG-47039|ENSG00000096968|3717|; TLE1|IDBG-73128|ENSG00000196781|7088|; 
DNA Replication	16645	REACTOME	9606	6	105	0.0020326544531356788	0.008611627644964136	GMNN; MCM2; PCNA; PRIM1; PRIM2; UBC; 	GMNN|IDBG-65780|ENSG00000112312|51053|; MCM2|IDBG-54871|ENSG00000073111|4171|; PCNA|IDBG-50801|ENSG00000132646|5111|; PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; UBC|IDBG-64029|ENSG00000150991|7316|; 
FSH	15929	NETPATH	9606	4	44	0.002184125336285311	0.008979181938061834	AKT2; EGFR; HIST3H3; YWHAQ; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; YWHAQ|IDBG-27933|ENSG00000134308|10971|; 
Lagging Strand Synthesis	19630	REACTOME	9606	3	21	0.0021815286424720255	0.00903543579531324	PCNA; PRIM1; PRIM2; 	PCNA|IDBG-50801|ENSG00000132646|5111|; PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; 
activated TAK1 mediates p38 MAPK activation	13024	REACTOME	9606	3	21	0.0021815286424720255	0.00903543579531324	MAP3K7; TAB1; UBC; 	MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; UBC|IDBG-64029|ENSG00000150991|7316|; 
regulation of FZD by ubiquitination	18257	REACTOME	9606	3	21	0.0021815286424720255	0.00903543579531324	LRP5; LRP6; UBC; 	LRP5|IDBG-61383|ENSG00000162337|4041|; LRP6|IDBG-20075|ENSG00000070018|4040|; UBC|IDBG-64029|ENSG00000150991|7316|; 
DNA replication initiation	12948	REACTOME	9606	2	6	0.0022724683371056075	0.009205984869296437	PRIM1; PRIM2; 	PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; 
Telomere C-strand synthesis initiation	12915	REACTOME	9606	2	6	0.0022724683371056075	0.009205984869296437	PRIM1; PRIM2; 	PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; 
Telomere C-strand (Lagging Strand) Synthesis	12918	REACTOME	9606	3	23	0.0028522521041379717	0.011471013897076623	PCNA; PRIM1; PRIM2; 	PCNA|IDBG-50801|ENSG00000132646|5111|; PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; 
Tpo signaling pathway	4124	PID BIOCARTA	9606	3	24	0.003230080159020957	0.012897082649328283	CSNK2A1; JAK2; SHC1; 	CSNK2A1|IDBG-37787|ENSG00000101266|1457|; JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
DNA Replication Pre-Initiation	17908	REACTOME	9606	5	82	0.0036400373847485018	0.013932556886451161	GMNN; MCM2; PRIM1; PRIM2; UBC; 	GMNN|IDBG-65780|ENSG00000112312|51053|; MCM2|IDBG-54871|ENSG00000073111|4171|; PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; UBC|IDBG-64029|ENSG00000150991|7316|; 
M/G1 Transition	18934	REACTOME	9606	5	82	0.0036400373847485018	0.013932556886451161	GMNN; MCM2; PRIM1; PRIM2; UBC; 	GMNN|IDBG-65780|ENSG00000112312|51053|; MCM2|IDBG-54871|ENSG00000073111|4171|; PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Activation of BH3-only proteins	18409	REACTOME	9606	3	25	0.00363719305270982	0.014116378631146504	AKT2; YWHAE; YWHAQ; 	AKT2|IDBG-51270|ENSG00000105221|208|; YWHAE|IDBG-14629|ENSG00000108953|7531|; YWHAQ|IDBG-27933|ENSG00000134308|10971|; 
Cellular response to hypoxia	18542	REACTOME	9606	3	25	0.00363719305270982	0.014116378631146504	EP300; UBC; VHL; 	EP300|IDBG-8992|ENSG00000100393|2033|; UBC|IDBG-64029|ENSG00000150991|7316|; VHL|IDBG-17819|ENSG00000134086|7428|; 
Downregulation of TGF-beta receptor signaling	13267	REACTOME	9606	3	25	0.00363719305270982	0.014116378631146504	SMAD2; SMAD3; UBC; 	SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Regulation of Hypoxia-inducible Factor (HIF) by oxygen	18380	REACTOME	9606	3	25	0.00363719305270982	0.014116378631146504	EP300; UBC; VHL; 	EP300|IDBG-8992|ENSG00000100393|2033|; UBC|IDBG-64029|ENSG00000150991|7316|; VHL|IDBG-17819|ENSG00000134086|7428|; 
MyD88 cascade initiated on plasma membrane	13043	REACTOME	9606	5	83	0.0038351585354162994	0.014381844507811123	APP; JAK2; MAP3K7; TAB1; UBC; 	APP|IDBG-1100|ENSG00000142192|351|; JAK2|IDBG-47039|ENSG00000096968|3717|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Toll Like Receptor 10 (TLR10) Cascade	13044	REACTOME	9606	5	83	0.0038351585354162994	0.014381844507811123	APP; JAK2; MAP3K7; TAB1; UBC; 	APP|IDBG-1100|ENSG00000142192|351|; JAK2|IDBG-47039|ENSG00000096968|3717|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Toll Like Receptor 5 (TLR5) Cascade	13048	REACTOME	9606	5	83	0.0038351585354162994	0.014381844507811123	APP; JAK2; MAP3K7; TAB1; UBC; 	APP|IDBG-1100|ENSG00000142192|351|; JAK2|IDBG-47039|ENSG00000096968|3717|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; UBC|IDBG-64029|ENSG00000150991|7316|; 
RANKL	15925	NETPATH	9606	5	84	0.004037668394770783	0.014939373060651899	AKT2; CYLD; EGFR; MAP3K7; TAB1; 	AKT2|IDBG-51270|ENSG00000105221|208|; CYLD|IDBG-30697|ENSG00000083799|102724054,1540|; EGFR|IDBG-16933|ENSG00000146648|1956|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; 
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation	13040	REACTOME	9606	5	84	0.004037668394770783	0.014939373060651899	APP; JAK2; MAP3K7; TAB1; UBC; 	APP|IDBG-1100|ENSG00000142192|351|; JAK2|IDBG-47039|ENSG00000096968|3717|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; UBC|IDBG-64029|ENSG00000150991|7316|; 
WNT mediated activation of DVL	16827	REACTOME	9606	2	8	0.004172623902587947	0.015336465337326561	CSNK1E; CSNK2A1; 	CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; CSNK2A1|IDBG-37787|ENSG00000101266|1457|; 
IL6	15922	NETPATH	9606	5	85	0.004247719868767824	0.01550976662609304	AR; EP300; JAK2; MAP3K7; SHC1; 	AR|IDBG-73722|ENSG00000169083|367|; EP300|IDBG-8992|ENSG00000100393|2033|; JAK2|IDBG-47039|ENSG00000096968|3717|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
MyD88 dependent cascade initiated on endosome	13041	REACTOME	9606	5	86	0.004465465446377071	0.016093073524281003	APP; JAK2; MAP3K7; TAB1; UBC; 	APP|IDBG-1100|ENSG00000142192|351|; JAK2|IDBG-47039|ENSG00000096968|3717|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Toll Like Receptor 7/8 (TLR7/8) Cascade	16831	REACTOME	9606	5	86	0.004465465446377071	0.016093073524281003	APP; JAK2; MAP3K7; TAB1; UBC; 	APP|IDBG-1100|ENSG00000142192|351|; JAK2|IDBG-47039|ENSG00000096968|3717|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Multi-step regulation of transcription by pitx2	4152	PID BIOCARTA	9606	3	27	0.004541953720809396	0.016263124613220742	CSNK2A1; EP300; LRP6; 	CSNK2A1|IDBG-37787|ENSG00000101266|1457|; EP300|IDBG-8992|ENSG00000100393|2033|; LRP6|IDBG-20075|ENSG00000070018|4040|; 
Validated transcriptional targets of TAp63 isoforms	15683	PID NCI	9606	4	54	0.004621536938627868	0.01644200641627222	AEN; EP300; SP1; YWHAQ; 	AEN|IDBG-28670|ENSG00000181026|64782|; EP300|IDBG-8992|ENSG00000100393|2033|; SP1|IDBG-36616|ENSG00000185591|6667|; YWHAQ|IDBG-27933|ENSG00000134308|10971|; 
BARD1 signaling events	15606	PID NCI	9606	3	28	0.005040844868692209	0.01737682547903215	EWSR1; PCNA; RAD51; 	EWSR1|IDBG-3488|ENSG00000182944|2130|; PCNA|IDBG-50801|ENSG00000132646|5111|; RAD51|IDBG-6509|ENSG00000051180|5888|; 
Nfkb activation by nontypeable hemophilus influenzae	4159	PID BIOCARTA	9606	3	28	0.005040844868692209	0.01737682547903215	EP300; MAP3K7; SMAD3; 	EP300|IDBG-8992|ENSG00000100393|2033|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; SMAD3|IDBG-18366|ENSG00000166949|4088|; 
SHC1 events in ERBB2 signaling	13289	REACTOME	9606	3	28	0.005040844868692209	0.01737682547903215	EGFR; JAK2; SHC1; 	EGFR|IDBG-16933|ENSG00000146648|1956|; JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
YAP1- and WWTR1 (TAZ)-stimulated gene expression	13740	REACTOME	9606	3	28	0.005040844868692209	0.01737682547903215	NCOA6; TBL1X; TBL1XR1; 	NCOA6|IDBG-68724|ENSG00000198646|23054|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; 
RMTs methylate histone arginines	18864	REACTOME	9606	4	55	0.00493639222587787	0.017450303728421768	HIST2H2AC; JAK2; SMARCB1; WDR5; 	HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; JAK2|IDBG-47039|ENSG00000096968|3717|; SMARCB1|IDBG-2584|ENSG00000099956|6598|; WDR5|IDBG-91736|ENSG00000196363|11091|; 
Toll Like Receptor 9 (TLR9) Cascade	13042	REACTOME	9606	5	89	0.005166383985441354	0.017699648839012046	APP; JAK2; MAP3K7; TAB1; UBC; 	APP|IDBG-1100|ENSG00000142192|351|; JAK2|IDBG-47039|ENSG00000096968|3717|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; UBC|IDBG-64029|ENSG00000150991|7316|; 
EGFR-dependent Endothelin signaling events	15405	PID NCI	9606	2	9	0.005320853217114126	0.01811701555520454	EGFR; SHC1; 	EGFR|IDBG-16933|ENSG00000146648|1956|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Extension of Telomeres	19607	REACTOME	9606	3	29	0.005571509722800794	0.018740532703966306	PCNA; PRIM1; PRIM2; 	PCNA|IDBG-50801|ENSG00000132646|5111|; PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; 
HIF-2-alpha transcription factor network	15324	PID NCI	9606	3	29	0.005571509722800794	0.018740532703966306	SIRT1; SP1; VHL; 	SIRT1|IDBG-75847|ENSG00000096717|23411|; SP1|IDBG-36616|ENSG00000185591|6667|; VHL|IDBG-17819|ENSG00000134086|7428|; 
MyD88:Mal cascade initiated on plasma membrane	13034	REACTOME	9606	5	92	0.0059419846968434015	0.019747314411665197	APP; JAK2; MAP3K7; TAB1; UBC; 	APP|IDBG-1100|ENSG00000142192|351|; JAK2|IDBG-47039|ENSG00000096968|3717|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Toll Like Receptor TLR6:TLR2 Cascade	13036	REACTOME	9606	5	92	0.0059419846968434015	0.019747314411665197	APP; JAK2; MAP3K7; TAB1; UBC; 	APP|IDBG-1100|ENSG00000142192|351|; JAK2|IDBG-47039|ENSG00000096968|3717|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Activation of the pre-replicative complex	12957	REACTOME	9606	3	30	0.006134477891601977	0.020027266057877042	MCM2; PRIM1; PRIM2; 	MCM2|IDBG-54871|ENSG00000073111|4171|; PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; 
Mcalpain and friends in cell motility	4086	PID BIOCARTA	9606	3	30	0.006134477891601977	0.020027266057877042	ACTA1; EGFR; SHC1; 	ACTA1|IDBG-107311|ENSG00000143632|58|; EGFR|IDBG-16933|ENSG00000146648|1956|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Vegf hypoxia and angiogenesis	3979	PID BIOCARTA	9606	3	30	0.006134477891601977	0.020027266057877042	ACTA1; SHC1; VHL; 	ACTA1|IDBG-107311|ENSG00000143632|58|; SHC1|IDBG-103007|ENSG00000160691|6464|; VHL|IDBG-17819|ENSG00000134086|7428|; 
EGFR1	15908	NETPATH	9606	13	472	0.006225580630692544	0.020205831871545975	AHCYL1; APP; CYLD; EGFR; HIST3H3; HUWE1; JAK2; RALB; RBM3; SHC1; SMAD2; SMAD3; SP1; 	AHCYL1|IDBG-100935|ENSG00000168710|10768|; APP|IDBG-1100|ENSG00000142192|351|; CYLD|IDBG-30697|ENSG00000083799|102724054,1540|; EGFR|IDBG-16933|ENSG00000146648|1956|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; HUWE1|IDBG-70116|ENSG00000086758|10075|; JAK2|IDBG-47039|ENSG00000096968|3717|; RALB|IDBG-68212|ENSG00000144118|5899|; RBM3|IDBG-63532|ENSG00000102317|5935|; SHC1|IDBG-103007|ENSG00000160691|6464|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SP1|IDBG-36616|ENSG00000185591|6667|; 
MAP kinase activation in TLR cascade	18088	REACTOME	9606	4	59	0.0063395121908506845	0.020455984104198428	JAK2; MAP3K7; TAB1; UBC; 	JAK2|IDBG-47039|ENSG00000096968|3717|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; UBC|IDBG-64029|ENSG00000150991|7316|; 
LIF signaling	16169	INOH	9606	2	10	0.006596633730351292	0.021040986898534293	EP300; JAK2; 	EP300|IDBG-8992|ENSG00000100393|2033|; JAK2|IDBG-47039|ENSG00000096968|3717|; 
Overview of telomerase protein component gene htert transcriptional regulation	3983	PID BIOCARTA	9606	2	10	0.006596633730351292	0.021040986898534293	ESR1; SP1; 	ESR1|IDBG-97997|ENSG00000091831|2099|; SP1|IDBG-36616|ENSG00000185591|6667|; 
Toll Like Receptor 2 (TLR2) Cascade	17710	REACTOME	9606	5	95	0.006796277378797028	0.021190640141754778	APP; JAK2; MAP3K7; TAB1; UBC; 	APP|IDBG-1100|ENSG00000142192|351|; JAK2|IDBG-47039|ENSG00000096968|3717|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Toll Like Receptor TLR1:TLR2 Cascade	13035	REACTOME	9606	5	95	0.006796277378797028	0.021190640141754778	APP; JAK2; MAP3K7; TAB1; UBC; 	APP|IDBG-1100|ENSG00000142192|351|; JAK2|IDBG-47039|ENSG00000096968|3717|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Signalling to RAS	13184	REACTOME	9606	3	31	0.006730243982755529	0.021223212559257493	JAK2; RALB; SHC1; 	JAK2|IDBG-47039|ENSG00000096968|3717|; RALB|IDBG-68212|ENSG00000144118|5899|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
TGF-beta receptor signaling activates SMADs	13268	REACTOME	9606	3	31	0.006730243982755529	0.021223212559257493	SMAD2; SMAD3; UBC; 	SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Loss of Nlp from mitotic centrosomes	12976	REACTOME	9606	4	61	0.007131046029668967	0.02198739192481265	CSNK1E; ODF2; TUBA4A; YWHAE; 	CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; ODF2|IDBG-88092|ENSG00000136811|4957|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; YWHAE|IDBG-14629|ENSG00000108953|7531|; 
Loss of proteins required for interphase microtubule organization?from the centrosome	12977	REACTOME	9606	4	61	0.007131046029668967	0.02198739192481265	CSNK1E; ODF2; TUBA4A; YWHAE; 	CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; ODF2|IDBG-88092|ENSG00000136811|4957|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; YWHAE|IDBG-14629|ENSG00000108953|7531|; 
MyD88-independent cascade 	13030	REACTOME	9606	5	97	0.0074114698442290135	0.022355248714929905	APP; JAK2; MAP3K7; TAB1; UBC; 	APP|IDBG-1100|ENSG00000142192|351|; JAK2|IDBG-47039|ENSG00000096968|3717|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Synthesis of DNA	16950	REACTOME	9606	5	97	0.0074114698442290135	0.022355248714929905	MCM2; PCNA; PRIM1; PRIM2; UBC; 	MCM2|IDBG-54871|ENSG00000073111|4171|; PCNA|IDBG-50801|ENSG00000132646|5111|; PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; UBC|IDBG-64029|ENSG00000150991|7316|; 
TRIF-mediated TLR3/TLR4 signaling 	19507	REACTOME	9606	5	97	0.0074114698442290135	0.022355248714929905	APP; JAK2; MAP3K7; TAB1; UBC; 	APP|IDBG-1100|ENSG00000142192|351|; JAK2|IDBG-47039|ENSG00000096968|3717|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Toll Like Receptor 3 (TLR3) Cascade	13031	REACTOME	9606	5	97	0.0074114698442290135	0.022355248714929905	APP; JAK2; MAP3K7; TAB1; UBC; 	APP|IDBG-1100|ENSG00000142192|351|; JAK2|IDBG-47039|ENSG00000096968|3717|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; UBC|IDBG-64029|ENSG00000150991|7316|; 
E2F mediated regulation of DNA replication	12968	REACTOME	9606	3	33	0.00802197923150292	0.023556605679810157	PCNA; PRIM1; PRIM2; 	PCNA|IDBG-50801|ENSG00000132646|5111|; PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; 
Condensation of Prometaphase Chromosomes	12938	REACTOME	9606	2	11	0.00799663265081059	0.02360708043191424	CCNB2; CSNK2A1; 	CCNB2|IDBG-14456|ENSG00000157456|9133|; CSNK2A1|IDBG-37787|ENSG00000101266|1457|; 
Epo signaling pathway	4020	PID BIOCARTA	9606	2	11	0.00799663265081059	0.02360708043191424	JAK2; SHC1; 	JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
IL-5 signaling	16159	INOH	9606	2	11	0.00799663265081059	0.02360708043191424	JAK2; SHC1; 	JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Meiotic recombination	13921	REACTOME	9606	4	63	0.007985299291307394	0.02395589787392218	HIST2H2AC; HIST2H2BE; HIST3H3; RAD51; 	HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; RAD51|IDBG-6509|ENSG00000051180|5888|; 
Carm1 and regulation of the estrogen receptor	4134	PID BIOCARTA	9606	2	12	0.00951757960153649	0.027369205589910635	EP300; ESR1; 	EP300|IDBG-8992|ENSG00000100393|2033|; ESR1|IDBG-97997|ENSG00000091831|2099|; 
Downregulation of ERBB2:ERBB3 signaling	13285	REACTOME	9606	2	12	0.00951757960153649	0.027369205589910635	AKT2; UBC; 	AKT2|IDBG-51270|ENSG00000105221|208|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Il 3 signaling pathway	3967	PID BIOCARTA	9606	2	12	0.00951757960153649	0.027369205589910635	JAK2; SHC1; 	JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Inhibition of replication initiation of damaged DNA by RB1/E2F1	12966	REACTOME	9606	2	12	0.00951757960153649	0.027369205589910635	PRIM1; PRIM2; 	PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; 
AP-1 transcription factor network	15318	PID NCI	9606	4	67	0.009889654782348956	0.028292569093833354	ACTA1; EP300; ESR1; SP1; 	ACTA1|IDBG-107311|ENSG00000143632|58|; EP300|IDBG-8992|ENSG00000100393|2033|; ESR1|IDBG-97997|ENSG00000091831|2099|; SP1|IDBG-36616|ENSG00000185591|6667|; 
Prolactin	15931	NETPATH	9606	5	105	0.01026205968256782	0.028910878801142844	EGFR; EP300; ESR1; JAK2; SHC1; 	EGFR|IDBG-16933|ENSG00000146648|1956|; EP300|IDBG-8992|ENSG00000100393|2033|; ESR1|IDBG-97997|ENSG00000091831|2099|; JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Role of Calcineurin-dependent NFAT signaling in lymphocytes	15595	PID NCI	9606	3	36	0.010216026518917733	0.02892803427550685	CSNK2A1; KPNB1; YWHAQ; 	CSNK2A1|IDBG-37787|ENSG00000101266|1457|; KPNB1|IDBG-56053|ENSG00000108424|3837|; YWHAQ|IDBG-27933|ENSG00000134308|10971|; 
Signaling events mediated by TCPTP	15420	PID NCI	9606	3	36	0.010216026518917733	0.02892803427550685	EGFR; KPNB1; SHC1; 	EGFR|IDBG-16933|ENSG00000146648|1956|; KPNB1|IDBG-56053|ENSG00000108424|3837|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Erythropoietin mediated neuroprotection through nf-kb	4161	PID BIOCARTA	9606	2	13	0.011156265597890147	0.030501120230684887	EP300; JAK2; 	EP300|IDBG-8992|ENSG00000100393|2033|; JAK2|IDBG-47039|ENSG00000096968|3717|; 
Il 6 signaling pathway	3992	PID BIOCARTA	9606	2	13	0.011156265597890147	0.030501120230684887	JAK2; SHC1; 	JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Signaling by Activin	13273	REACTOME	9606	2	13	0.011156265597890147	0.030501120230684887	SMAD2; SMAD3; 	SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; 
repression of WNT target genes	18872	REACTOME	9606	2	13	0.011156265597890147	0.030501120230684887	TLE1; TLE2; 	TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; 
FCERI mediated NF-kB activation	16799	REACTOME	9606	3	37	0.011017128034166114	0.03072616110031253	MAP3K7; TAB1; UBC; 	MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; UBC|IDBG-64029|ENSG00000150991|7316|; 
FOXM1 transcription factor network	15700	PID NCI	9606	3	37	0.011017128034166114	0.03072616110031253	CCNB2; ESR1; SP1; 	CCNB2|IDBG-14456|ENSG00000157456|9133|; ESR1|IDBG-97997|ENSG00000091831|2099|; SP1|IDBG-36616|ENSG00000185591|6667|; 
Intrinsic Pathway for Apoptosis	19328	REACTOME	9606	3	38	0.011853589632367852	0.03224873649982431	AKT2; YWHAE; YWHAQ; 	AKT2|IDBG-51270|ENSG00000105221|208|; YWHAE|IDBG-14629|ENSG00000108953|7531|; YWHAQ|IDBG-27933|ENSG00000134308|10971|; 
G1/S Transition	17967	REACTOME	9606	5	109	0.011936436925598893	0.032315719481499444	MCM2; PCNA; PRIM1; PRIM2; UBC; 	MCM2|IDBG-54871|ENSG00000073111|4171|; PCNA|IDBG-50801|ENSG00000132646|5111|; PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Activated TLR4 signalling	19190	REACTOME	9606	5	110	0.012382384430295788	0.033199146660937984	APP; JAK2; MAP3K7; TAB1; UBC; 	APP|IDBG-1100|ENSG00000142192|351|; JAK2|IDBG-47039|ENSG00000096968|3717|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Signaling by Interleukins	18744	REACTOME	9606	5	110	0.012382384430295788	0.033199146660937984	JAK2; MAP3K7; SHC1; TAB1; UBC; 	JAK2|IDBG-47039|ENSG00000096968|3717|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; SHC1|IDBG-103007|ENSG00000160691|6464|; TAB1|IDBG-8281|ENSG00000100324|10454|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Attenuation phase	17488	REACTOME	9606	2	14	0.012909542041577168	0.034446133812862156	DNAJB1; EP300; 	DNAJB1|IDBG-33491|ENSG00000132002|3337|; EP300|IDBG-8992|ENSG00000100393|2033|; 
IL4	15920	NETPATH	9606	4	74	0.013887152341867017	0.03687736626668035	EP300; HIST3H3; JAK2; SHC1; 	EP300|IDBG-8992|ENSG00000100393|2033|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Association of licensing factors with the pre-replicative complex	12933	REACTOME	9606	2	15	0.014774319730926851	0.037613520415891756	GMNN; UBC; 	GMNN|IDBG-65780|ENSG00000112312|51053|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Calcium signaling by hbx of hepatitis b virus	4105	PID BIOCARTA	9606	2	15	0.014774319730926851	0.037613520415891756	CSNK2A1; SHC1; 	CSNK2A1|IDBG-37787|ENSG00000101266|1457|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Canonical Wnt signaling pathway	15524	PID NCI	9606	2	15	0.014774319730926851	0.037613520415891756	CUL3; LRP6; 	CUL3|IDBG-82331|ENSG00000036257|8452|; LRP6|IDBG-20075|ENSG00000070018|4040|; 
Estrogen responsive protein efp controls cell cycle and breast tumors growth	4072	PID BIOCARTA	9606	2	15	0.014774319730926851	0.037613520415891756	CCNB2; ESR1; 	CCNB2|IDBG-14456|ENSG00000157456|9133|; ESR1|IDBG-97997|ENSG00000091831|2099|; 
Mechanisms of transcriptional repression by dna methylation	3966	PID BIOCARTA	9606	2	15	0.014774319730926851	0.037613520415891756	CHD3; CHD4; 	CHD3|IDBG-27053|ENSG00000170004|1107|; CHD4|IDBG-14532|ENSG00000111642|1108|; 
Nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription in carcinoma cells	3941	PID BIOCARTA	9606	2	15	0.014774319730926851	0.037613520415891756	HDAC3; NCOR2; 	HDAC3|IDBG-50725|ENSG00000171720|8841|; NCOR2|IDBG-63911|ENSG00000196498|9612|; 
negative regulation of TCF-dependent signaling by WNT ligand antagonists	18430	REACTOME	9606	2	15	0.014774319730926851	0.037613520415891756	LRP5; LRP6; 	LRP5|IDBG-61383|ENSG00000162337|4041|; LRP6|IDBG-20075|ENSG00000070018|4040|; 
HATs acetylate histones	16644	REACTOME	9606	5	114	0.014279267500456081	0.037738064108348214	EP300; HIST2H2AC; HIST2H2BE; MBIP; WDR5; 	EP300|IDBG-8992|ENSG00000100393|2033|; HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; MBIP|IDBG-4937|ENSG00000151332|51562|; WDR5|IDBG-91736|ENSG00000196363|11091|; 
Signalling to ERKs	18748	REACTOME	9606	3	41	0.014577483835369007	0.038343618619098574	JAK2; RALB; SHC1; 	JAK2|IDBG-47039|ENSG00000096968|3717|; RALB|IDBG-68212|ENSG00000144118|5899|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Translocation of GLUT4 to the plasma membrane	13827	REACTOME	9606	4	77	0.015873082538886647	0.040226305064301776	AKT2; TUBA4A; YWHAE; YWHAQ; 	AKT2|IDBG-51270|ENSG00000105221|208|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; YWHAE|IDBG-14629|ENSG00000108953|7531|; YWHAQ|IDBG-27933|ENSG00000134308|10971|; 
CRMPs in Sema3A signaling	13906	REACTOME	9606	2	16	0.016747567885044595	0.041127876885839604	DPYSL2; DPYSL5; 	DPYSL2|IDBG-13200|ENSG00000092964|102723812,1808|; DPYSL5|IDBG-36183|ENSG00000157851|56896|; 
Glypican 1 network	15119	PID NCI	9606	2	16	0.016747567885044595	0.041127876885839604	APP; SMAD2; 	APP|IDBG-1100|ENSG00000142192|351|; SMAD2|IDBG-3127|ENSG00000175387|4087|; 
Hypoxia-inducible factor in the cardivascular system	3949	PID BIOCARTA	9606	2	16	0.016747567885044595	0.041127876885839604	EP300; VHL; 	EP300|IDBG-8992|ENSG00000100393|2033|; VHL|IDBG-17819|ENSG00000134086|7428|; 
Nongenotropic Androgen signaling	14920	PID NCI	9606	2	16	0.016747567885044595	0.041127876885839604	AR; SHBG; 	AR|IDBG-73722|ENSG00000169083|367|; SHBG|IDBG-26209|ENSG00000129214|6462|; 
Polo-like kinase mediated events	12971	REACTOME	9606	2	16	0.016747567885044595	0.041127876885839604	CCNB2; EP300; 	CCNB2|IDBG-14456|ENSG00000157456|9133|; EP300|IDBG-8992|ENSG00000100393|2033|; 
Interleukin-1 signaling	13078	REACTOME	9606	3	43	0.016574063574945723	0.04162264834432071	MAP3K7; TAB1; UBC; 	MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; UBC|IDBG-64029|ENSG00000150991|7316|; 
RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways	13017	REACTOME	9606	4	78	0.016572688562913208	0.041808373420076504	APP; CYLD; EP300; UBC; 	APP|IDBG-1100|ENSG00000142192|351|; CYLD|IDBG-30697|ENSG00000083799|102724054,1540|; EP300|IDBG-8992|ENSG00000100393|2033|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Antigen processing: Ubiquitination & Proteasome degradation	12981	REACTOME	9606	7	212	0.01732825922855533	0.041996436121607895	CUL3; DZIP3; FBXO6; HUWE1; UBC; UBE3A; VHL; 	CUL3|IDBG-82331|ENSG00000036257|8452|; DZIP3|IDBG-49039|ENSG00000198919|9666|; FBXO6|IDBG-89462|ENSG00000116663|26270|; HUWE1|IDBG-70116|ENSG00000086758|10075|; UBC|IDBG-64029|ENSG00000150991|7316|; UBE3A|IDBG-4274|ENSG00000114062|7337|; VHL|IDBG-17819|ENSG00000134086|7428|; 
Centrosome maturation	18712	REACTOME	9606	4	79	0.017291366761330886	0.0420908269848186	CSNK1E; ODF2; TUBA4A; YWHAE; 	CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; ODF2|IDBG-88092|ENSG00000136811|4957|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; YWHAE|IDBG-14629|ENSG00000108953|7531|; 
Recruitment of mitotic centrosome proteins and complexes	12979	REACTOME	9606	4	79	0.017291366761330886	0.0420908269848186	CSNK1E; ODF2; TUBA4A; YWHAE; 	CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; ODF2|IDBG-88092|ENSG00000136811|4957|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; YWHAE|IDBG-14629|ENSG00000108953|7531|; 
SHP2 signaling	15583	PID NCI	9606	3	44	0.01762698588502262	0.042350550502976425	EGFR; JAK2; SHC1; 	EGFR|IDBG-16933|ENSG00000146648|1956|; JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
SIRT1 negatively regulates rRNA Expression	17988	REACTOME	9606	3	44	0.01762698588502262	0.042350550502976425	HIST2H2AC; HIST2H2BE; SIRT1; 	HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; SIRT1|IDBG-75847|ENSG00000096717|23411|; 
TGF-beta signaling pathway	465	KEGG	9606	4	80	0.01802926249000405	0.043130347767035546	EP300; SMAD2; SMAD3; SP1; 	EP300|IDBG-8992|ENSG00000100393|2033|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SP1|IDBG-36616|ENSG00000185591|6667|; 
Oncostatin_M	16513	NETPATH	9606	3	45	0.018716469087488696	0.04420272486619671	EP300; JAK2; SHC1; 	EP300|IDBG-8992|ENSG00000100393|2033|; JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Signaling events mediated by PTP1B	15198	PID NCI	9606	3	45	0.018716469087488696	0.04420272486619671	EGFR; JAK2; SHC1; 	EGFR|IDBG-16933|ENSG00000146648|1956|; JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Nerve growth factor pathway (ngf)	4099	PID BIOCARTA	9606	2	17	0.0188263131847498	0.04427374498955991	CSNK2A1; SHC1; 	CSNK2A1|IDBG-37787|ENSG00000101266|1457|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Toll Like Receptor 4 (TLR4) Cascade	13046	REACTOME	9606	5	122	0.018639728894754484	0.04439935423428643	APP; JAK2; MAP3K7; TAB1; UBC; 	APP|IDBG-1100|ENSG00000142192|351|; JAK2|IDBG-47039|ENSG00000096968|3717|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Cytokine Signaling in Immune system	17418	REACTOME	9606	8	267	0.019149207708289546	0.04484308134219704	ARIH1; ICAM1; JAK2; KPNB1; MAP3K7; SHC1; TAB1; UBC; 	ARIH1|IDBG-20750|ENSG00000166233|25820|; ICAM1|IDBG-26804|ENSG00000090339|3383|; JAK2|IDBG-47039|ENSG00000096968|3717|; KPNB1|IDBG-56053|ENSG00000108424|3837|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; SHC1|IDBG-103007|ENSG00000160691|6464|; TAB1|IDBG-8281|ENSG00000100324|10454|; UBC|IDBG-64029|ENSG00000150991|7316|; 
S Phase	17420	REACTOME	9606	5	124	0.019852904729277643	0.046295639179618035	MCM2; PCNA; PRIM1; PRIM2; UBC; 	MCM2|IDBG-54871|ENSG00000073111|4171|; PCNA|IDBG-50801|ENSG00000132646|5111|; PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; UBC|IDBG-64029|ENSG00000150991|7316|; 
IGF1R signaling cascade	19000	REACTOME	9606	4	83	0.020359616879102115	0.04688625463859615	AKT2; JAK2; PPM1A; SHC1; 	AKT2|IDBG-51270|ENSG00000105221|208|; JAK2|IDBG-47039|ENSG00000096968|3717|; PPM1A|IDBG-8210|ENSG00000100614|5494|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Insulin receptor signalling cascade	18606	REACTOME	9606	4	83	0.020359616879102115	0.04688625463859615	AKT2; JAK2; PPM1A; SHC1; 	AKT2|IDBG-51270|ENSG00000105221|208|; JAK2|IDBG-47039|ENSG00000096968|3717|; PPM1A|IDBG-8210|ENSG00000100614|5494|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)	13284	REACTOME	9606	4	83	0.020359616879102115	0.04688625463859615	AKT2; JAK2; PPM1A; SHC1; 	AKT2|IDBG-51270|ENSG00000105221|208|; JAK2|IDBG-47039|ENSG00000096968|3717|; PPM1A|IDBG-8210|ENSG00000100614|5494|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Signalling by NGF	16818	REACTOME	9606	8	271	0.020732941192675935	0.04754868744601299	AKT2; EGFR; HDAC3; JAK2; RALB; SHC1; UBC; YWHAE; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; HDAC3|IDBG-50725|ENSG00000171720|8841|; JAK2|IDBG-47039|ENSG00000096968|3717|; RALB|IDBG-68212|ENSG00000144118|5899|; SHC1|IDBG-103007|ENSG00000160691|6464|; UBC|IDBG-64029|ENSG00000150991|7316|; YWHAE|IDBG-14629|ENSG00000108953|7531|; 
Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha	13922	REACTOME	9606	2	18	0.021007638823428754	0.04758873284491004	UBC; VHL; 	UBC|IDBG-64029|ENSG00000150991|7316|; VHL|IDBG-17819|ENSG00000134086|7428|; 
RNA Polymerase I Promoter Clearance	17889	REACTOME	9606	4	84	0.02117571430389878	0.04777447739294236	CHD3; CHD4; HIST2H2AC; HIST2H2BE; 	CHD3|IDBG-27053|ENSG00000170004|1107|; CHD4|IDBG-14532|ENSG00000111642|1108|; HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; 
Agrin in postsynaptic differentiation	4033	PID BIOCARTA	9606	3	47	0.021005402108374916	0.04777868102519704	ACTA1; EGFR; SP1; 	ACTA1|IDBG-107311|ENSG00000143632|58|; EGFR|IDBG-16933|ENSG00000146648|1956|; SP1|IDBG-36616|ENSG00000185591|6667|; 
G beta:gamma signalling through PI3Kgamma	13221	REACTOME	9606	3	47	0.021005402108374916	0.04777868102519704	AKT2; JAK2; SHC1; 	AKT2|IDBG-51270|ENSG00000105221|208|; JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Fc epsilon receptor (FCERI) signaling	17802	REACTOME	9606	6	173	0.02171847801305471	0.048800628733786905	AKT2; EGFR; JAK2; MAP3K7; TAB1; UBC; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; JAK2|IDBG-47039|ENSG00000096968|3717|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Insulin receptor signaling	16186	INOH	9606	4	85	0.022011664646049832	0.049259975316764744	AKT2; SHC1; YWHAE; YWHAQ; 	AKT2|IDBG-51270|ENSG00000105221|208|; SHC1|IDBG-103007|ENSG00000160691|6464|; YWHAE|IDBG-14629|ENSG00000108953|7531|; YWHAQ|IDBG-27933|ENSG00000134308|10971|; 
Interleukin-3, 5 and GM-CSF signaling	13082	REACTOME	9606	3	48	0.02220494058042797	0.04929496808855009	JAK2; SHC1; UBC; 	JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Regulation of Androgen receptor activity	15656	PID NCI	9606	3	48	0.02220494058042797	0.04929496808855009	AR; SIRT1; SRY; 	AR|IDBG-73722|ENSG00000169083|367|; SIRT1|IDBG-75847|ENSG00000096717|23411|; SRY|IDBG-1|ENSG00000184895|6736|; 
Pathways in cancer	4397	KEGG	9606	9	329	0.022605492827726732	0.04998425704935592	AKT2; AR; EGFR; EP300; RAD51; RALB; SMAD2; SMAD3; VHL; 	AKT2|IDBG-51270|ENSG00000105221|208|; AR|IDBG-73722|ENSG00000169083|367|; EGFR|IDBG-16933|ENSG00000146648|1956|; EP300|IDBG-8992|ENSG00000100393|2033|; RAD51|IDBG-6509|ENSG00000051180|5888|; RALB|IDBG-68212|ENSG00000144118|5899|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; VHL|IDBG-17819|ENSG00000134086|7428|; 
Condensation of Prophase Chromosomes	17113	REACTOME	9606	3	49	0.023441218612239793	0.050231182740513844	HIST2H2AC; HIST2H2BE; HIST3H3; 	HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; 
PRC2 methylates histones and DNA	16775	REACTOME	9606	3	49	0.023441218612239793	0.050231182740513844	HIST2H2AC; HIST2H2BE; SUZ12; 	HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; SUZ12|IDBG-39777|ENSG00000178691|23512|; 
Regulation of retinoblastoma protein	15024	PID NCI	9606	3	49	0.023441218612239793	0.050231182740513844	HDAC3; SIRT1; SMARCB1; 	HDAC3|IDBG-50725|ENSG00000171720|8841|; SIRT1|IDBG-75847|ENSG00000096717|23411|; SMARCB1|IDBG-2584|ENSG00000099956|6598|; 
RNA Polymerase I Transcription	16984	REACTOME	9606	4	86	0.022867576801773024	0.05036311557533345	CHD3; CHD4; HIST2H2AC; HIST2H2BE; 	CHD3|IDBG-27053|ENSG00000170004|1107|; CHD4|IDBG-14532|ENSG00000111642|1108|; HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; 
Downregulated of mta-3 in er-negative breast tumors	3959	PID BIOCARTA	9606	2	19	0.023288683578611385	0.05048913822706765	ESR1; TUBA4A; 	ESR1|IDBG-97997|ENSG00000091831|2099|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; 
GRB2 events in EGFR signaling	13214	REACTOME	9606	2	19	0.023288683578611385	0.05048913822706765	EGFR; JAK2; 	EGFR|IDBG-16933|ENSG00000146648|1956|; JAK2|IDBG-47039|ENSG00000096968|3717|; 
Signaling by NODAL	13884	REACTOME	9606	2	19	0.023288683578611385	0.05048913822706765	SMAD2; SMAD3; 	SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; 
Immune System	18444	REACTOME	9606	22	1127	0.023079925653846985	0.05062987643432837	AKT2; APP; ARIH1; CD81; CUL3; CYLD; DZIP3; EGFR; EP300; FBXO6; HUWE1; ICAM1; JAK2; KPNB1; MAP3K7; NCKIPSD; SHC1; TAB1; TUBA4A; UBC; UBE3A; VHL; 	AKT2|IDBG-51270|ENSG00000105221|208|; APP|IDBG-1100|ENSG00000142192|351|; ARIH1|IDBG-20750|ENSG00000166233|25820|; CD81|IDBG-22455|ENSG00000110651|975|; CUL3|IDBG-82331|ENSG00000036257|8452|; CYLD|IDBG-30697|ENSG00000083799|102724054,1540|; DZIP3|IDBG-49039|ENSG00000198919|9666|; EGFR|IDBG-16933|ENSG00000146648|1956|; EP300|IDBG-8992|ENSG00000100393|2033|; FBXO6|IDBG-89462|ENSG00000116663|26270|; HUWE1|IDBG-70116|ENSG00000086758|10075|; ICAM1|IDBG-26804|ENSG00000090339|3383|; JAK2|IDBG-47039|ENSG00000096968|3717|; KPNB1|IDBG-56053|ENSG00000108424|3837|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; NCKIPSD|IDBG-239383|ENSG00000213672|51517|; SHC1|IDBG-103007|ENSG00000160691|6464|; TAB1|IDBG-8281|ENSG00000100324|10454|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; UBC|IDBG-64029|ENSG00000150991|7316|; UBE3A|IDBG-4274|ENSG00000114062|7337|; VHL|IDBG-17819|ENSG00000134086|7428|; 
G-protein beta:gamma signalling	17727	REACTOME	9606	3	50	0.024714230250479648	0.05255324823377856	AKT2; JAK2; SHC1; 	AKT2|IDBG-51270|ENSG00000105221|208|; JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
GPVI-mediated activation cascade	13127	REACTOME	9606	3	50	0.024714230250479648	0.05255324823377856	AKT2; JAK2; SHC1; 	AKT2|IDBG-51270|ENSG00000105221|208|; JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Egf signaling pathway	4162	PID BIOCARTA	9606	2	20	0.025666640892789	0.05315293169961901	EGFR; SHC1; 	EGFR|IDBG-16933|ENSG00000146648|1956|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Igf-1 signaling pathway	4168	PID BIOCARTA	9606	2	20	0.025666640892789	0.05315293169961901	CSNK2A1; SHC1; 	CSNK2A1|IDBG-37787|ENSG00000101266|1457|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Nf-kb signaling pathway	3978	PID BIOCARTA	9606	2	20	0.025666640892789	0.05315293169961901	MAP3K7; TAB1; 	MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; 
SHC-mediated signalling	13279	REACTOME	9606	2	20	0.025666640892789	0.05315293169961901	JAK2; SHC1; 	JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Signal transduction by L1	13872	REACTOME	9606	2	20	0.025666640892789	0.05315293169961901	CSNK2A1; EGFR; 	CSNK2A1|IDBG-37787|ENSG00000101266|1457|; EGFR|IDBG-16933|ENSG00000146648|1956|; 
Sprouty regulation of tyrosine kinase signals	4142	PID BIOCARTA	9606	2	20	0.025666640892789	0.05315293169961901	EGFR; SHC1; 	EGFR|IDBG-16933|ENSG00000146648|1956|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
M Phase	18628	REACTOME	9606	8	281	0.025097444296361397	0.05316443352855182	CCNB2; CSNK2A1; HIST2H2AC; HIST2H2BE; HIST3H3; MIS12; TUBA4A; UBC; 	CCNB2|IDBG-14456|ENSG00000157456|9133|; CSNK2A1|IDBG-37787|ENSG00000101266|1457|; HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; MIS12|IDBG-21731|ENSG00000167842|79003|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; UBC|IDBG-64029|ENSG00000150991|7316|; 
IL-7 signaling	16106	INOH	9606	6	180	0.02578162280278124	0.0531925674927271	AKT2; CSNK1E; EGFR; JAK2; MAP3K7; YWHAQ; 	AKT2|IDBG-51270|ENSG00000105221|208|; CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; EGFR|IDBG-16933|ENSG00000146648|1956|; JAK2|IDBG-47039|ENSG00000096968|3717|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; YWHAQ|IDBG-27933|ENSG00000134308|10971|; 
Prostate cancer	544	KEGG	9606	4	90	0.02649281157491072	0.05425649602979871	AKT2; AR; EGFR; EP300; 	AKT2|IDBG-51270|ENSG00000105221|208|; AR|IDBG-73722|ENSG00000169083|367|; EGFR|IDBG-16933|ENSG00000146648|1956|; EP300|IDBG-8992|ENSG00000100393|2033|; 
EPO signaling pathway	16151	INOH	9606	6	181	0.026400725753797226	0.054268158493916516	AKT2; CSNK1E; EGFR; JAK2; MAP3K7; YWHAQ; 	AKT2|IDBG-51270|ENSG00000105221|208|; CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; EGFR|IDBG-16933|ENSG00000146648|1956|; JAK2|IDBG-47039|ENSG00000096968|3717|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; YWHAQ|IDBG-27933|ENSG00000134308|10971|; 
Keratinocyte differentiation	4032	PID BIOCARTA	9606	3	52	0.027370336458617382	0.05584756152401709	EGFR; SHC1; SP1; 	EGFR|IDBG-16933|ENSG00000146648|1956|; SHC1|IDBG-103007|ENSG00000160691|6464|; SP1|IDBG-36616|ENSG00000185591|6667|; 
Mitotic G1-G1/S phases	17361	REACTOME	9606	5	136	0.02822304543445682	0.05654797911957955	MCM2; PCNA; PRIM1; PRIM2; UBC; 	MCM2|IDBG-54871|ENSG00000073111|4171|; PCNA|IDBG-50801|ENSG00000132646|5111|; PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; UBC|IDBG-64029|ENSG00000150991|7316|; 
EGF signaling pathway 	16203	INOH	9606	2	21	0.028138757971720083	0.05658337200835016	EGFR; SHC1; 	EGFR|IDBG-16933|ENSG00000146648|1956|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Growth hormone signaling pathway	4113	PID BIOCARTA	9606	2	21	0.028138757971720083	0.05658337200835016	JAK2; SHC1; 	JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
IL3-mediated signaling events	15527	PID NCI	9606	2	21	0.028138757971720083	0.05658337200835016	JAK2; SHC1; 	JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
PDGFR-alpha signaling pathway	15770	PID NCI	9606	2	21	0.028138757971720083	0.05658337200835016	CSNK2A1; SHC1; 	CSNK2A1|IDBG-37787|ENSG00000101266|1457|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
GMCSF-mediated signaling events	15598	PID NCI	9606	2	22	0.030702334892677333	0.061074537152100074	JAK2; SHC1; 	JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
HSF1-dependent transactivation	18731	REACTOME	9606	2	22	0.030702334892677333	0.061074537152100074	DNAJB1; EP300; 	DNAJB1|IDBG-33491|ENSG00000132002|3337|; EP300|IDBG-8992|ENSG00000100393|2033|; 
Toll-Like Receptors Cascades	17767	REACTOME	9606	5	140	0.0314437948035639	0.06210429222767959	APP; JAK2; MAP3K7; TAB1; UBC; 	APP|IDBG-1100|ENSG00000142192|351|; JAK2|IDBG-47039|ENSG00000096968|3717|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Ubiquitin mediated proteolysis	519	KEGG	9606	5	140	0.0314437948035639	0.06210429222767959	CUL3; CUL4A; HUWE1; UBE3A; VHL; 	CUL3|IDBG-82331|ENSG00000036257|8452|; CUL4A|IDBG-52956|ENSG00000139842|8451|; HUWE1|IDBG-70116|ENSG00000086758|10075|; UBE3A|IDBG-4274|ENSG00000114062|7337|; VHL|IDBG-17819|ENSG00000134086|7428|; 
p75(NTR)-mediated signaling	15333	PID NCI	9606	3	55	0.03162879311502051	0.06224815666254036	APP; SHC1; YWHAE; 	APP|IDBG-1100|ENSG00000142192|351|; SHC1|IDBG-103007|ENSG00000160691|6464|; YWHAE|IDBG-14629|ENSG00000108953|7531|; 
Methionine Cysteine metabolism	16250	INOH	9606	2	23	0.0333547237297958	0.06405491927348328	AHCYL1; AHCYL2; 	AHCYL1|IDBG-100935|ENSG00000168710|10768|; AHCYL2|IDBG-40716|ENSG00000158467|23382|; 
SHC-related events	16715	REACTOME	9606	2	23	0.0333547237297958	0.06405491927348328	JAK2; SHC1; 	JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
SHC-related events triggered by IGF1R	13283	REACTOME	9606	2	23	0.0333547237297958	0.06405491927348328	JAK2; SHC1; 	JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Segmentation clock	3960	PID BIOCARTA	9606	2	23	0.0333547237297958	0.06405491927348328	CSNK2A1; LRP6; 	CSNK2A1|IDBG-37787|ENSG00000101266|1457|; LRP6|IDBG-20075|ENSG00000070018|4040|; 
Organelle biogenesis and maintenance	16766	REACTOME	9606	5	142	0.033137325340761886	0.06453058092674684	HDAC3; NCOA6; NCOR1; TBL1X; TBL1XR1; 	HDAC3|IDBG-50725|ENSG00000171720|8841|; NCOA6|IDBG-68724|ENSG00000198646|23054|; NCOR1|IDBG-31971|ENSG00000141027|9611|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; 
ATF-2 transcription factor network	15253	PID NCI	9606	3	56	0.033121063878159065	0.06472602271964184	CUL3; EP300; ESR1; 	CUL3|IDBG-82331|ENSG00000036257|8452|; EP300|IDBG-8992|ENSG00000100393|2033|; ESR1|IDBG-97997|ENSG00000091831|2099|; 
Pathogenic Escherichia coli infection	434	KEGG	9606	3	56	0.033121063878159065	0.06472602271964184	TUBA4A; TUBB8; YWHAQ; 	TUBA4A|IDBG-81457|ENSG00000127824|7277|; TUBB8|IDBG-777287|ENSG00000261456|347688|; YWHAQ|IDBG-27933|ENSG00000134308|10971|; 
Fas signaling pathway	16231	INOH	9606	2	24	0.03609332769054969	0.06836790740018797	YWHAE; YWHAQ; 	YWHAE|IDBG-14629|ENSG00000108953|7531|; YWHAQ|IDBG-27933|ENSG00000134308|10971|; 
Plasma membrane estrogen receptor signaling	15557	PID NCI	9606	2	24	0.03609332769054969	0.06836790740018797	ESR1; SHC1; 	ESR1|IDBG-97997|ENSG00000091831|2099|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Retinoic acid receptors-mediated signaling	15413	PID NCI	9606	2	24	0.03609332769054969	0.06836790740018797	HDAC3; NCOR2; 	HDAC3|IDBG-50725|ENSG00000171720|8841|; NCOR2|IDBG-63911|ENSG00000196498|9612|; 
a6b1 and a6b4 Integrin signaling	15252	PID NCI	9606	2	24	0.03609332769054969	0.06836790740018797	EGFR; SHC1; 	EGFR|IDBG-16933|ENSG00000146648|1956|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Amyloids	13692	REACTOME	9606	3	59	0.03781447385866582	0.07138446595768548	APP; HIST2H2AC; HIST2H2BE; 	APP|IDBG-1100|ENSG00000142192|351|; HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; 
Epigenetic regulation of gene expression	17815	REACTOME	9606	4	101	0.03815759976191178	0.07178802667071538	HIST2H2AC; HIST2H2BE; SIRT1; SUZ12; 	HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; SIRT1|IDBG-75847|ENSG00000096717|23411|; SUZ12|IDBG-39777|ENSG00000178691|23512|; 
EGFR downregulation	13215	REACTOME	9606	2	25	0.03891560026834075	0.07223464263855892	EGFR; UBC; 	EGFR|IDBG-16933|ENSG00000146648|1956|; UBC|IDBG-64029|ENSG00000150991|7316|; 
SHC1 events in ERBB4 signaling	13261	REACTOME	9606	2	25	0.03891560026834075	0.07223464263855892	JAK2; SHC1; 	JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Signaling events mediated by HDAC Class III	15506	PID NCI	9606	2	25	0.03891560026834075	0.07223464263855892	EP300; SIRT1; 	EP300|IDBG-8992|ENSG00000100393|2033|; SIRT1|IDBG-75847|ENSG00000096717|23411|; 
Wnt signaling network	15193	PID NCI	9606	2	25	0.03891560026834075	0.07223464263855892	LRP5; LRP6; 	LRP5|IDBG-61383|ENSG00000162337|4041|; LRP6|IDBG-20075|ENSG00000070018|4040|; 
Adaptive Immune System	18371	REACTOME	9606	13	604	0.039607503905974284	0.07230975219676226	AKT2; CD81; CUL3; DZIP3; EGFR; FBXO6; HUWE1; ICAM1; MAP3K7; TUBA4A; UBC; UBE3A; VHL; 	AKT2|IDBG-51270|ENSG00000105221|208|; CD81|IDBG-22455|ENSG00000110651|975|; CUL3|IDBG-82331|ENSG00000036257|8452|; DZIP3|IDBG-49039|ENSG00000198919|9666|; EGFR|IDBG-16933|ENSG00000146648|1956|; FBXO6|IDBG-89462|ENSG00000116663|26270|; HUWE1|IDBG-70116|ENSG00000086758|10075|; ICAM1|IDBG-26804|ENSG00000090339|3383|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; UBC|IDBG-64029|ENSG00000150991|7316|; UBE3A|IDBG-4274|ENSG00000114062|7337|; VHL|IDBG-17819|ENSG00000134086|7428|; 
Signaling by ERBB2	13291	REACTOME	9606	5	149	0.03950830530494399	0.07236669783578849	AKT2; EGFR; JAK2; SHC1; UBC; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Coregulation of Androgen receptor activity	15082	PID NCI	9606	3	60	0.03945062699964011	0.07250032445298099	AR; NCOA6; UBE3A; 	AR|IDBG-73722|ENSG00000169083|367|; NCOA6|IDBG-68724|ENSG00000198646|23054|; UBE3A|IDBG-4274|ENSG00000114062|7337|; 
IL4-mediated signaling events	15439	PID NCI	9606	3	60	0.03945062699964011	0.07250032445298099	JAK2; SHC1; SP1; 	JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; SP1|IDBG-36616|ENSG00000185591|6667|; 
Validated targets of C-MYC transcriptional repression	15263	PID NCI	9606	3	60	0.03945062699964011	0.07250032445298099	EP300; HDAC3; SP1; 	EP300|IDBG-8992|ENSG00000100393|2033|; HDAC3|IDBG-50725|ENSG00000171720|8841|; SP1|IDBG-36616|ENSG00000185591|6667|; 
Signal Transduction	17980	REACTOME	9606	33	1965	0.04151660988617603	0.07554661798959901	AKT2; APP; CHD8; CSNK1E; CSNK2A1; CUL3; EGFR; EP300; ESR1; HDAC3; HIST2H2AC; HIST2H2BE; HIST3H3; JAK2; LRP5; LRP6; MAP3K7; NCOR1; NCOR2; PPM1A; RALB; SHC1; SMAD2; SMAD3; SP1; TBL1X; TBL1XR1; TLE1; TLE2; TUBA4A; UBC; WWOX; YWHAE; 	AKT2|IDBG-51270|ENSG00000105221|208|; APP|IDBG-1100|ENSG00000142192|351|; CHD8|IDBG-2645|ENSG00000100888|57680|; CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; CSNK2A1|IDBG-37787|ENSG00000101266|1457|; CUL3|IDBG-82331|ENSG00000036257|8452|; EGFR|IDBG-16933|ENSG00000146648|1956|; EP300|IDBG-8992|ENSG00000100393|2033|; ESR1|IDBG-97997|ENSG00000091831|2099|; HDAC3|IDBG-50725|ENSG00000171720|8841|; HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; JAK2|IDBG-47039|ENSG00000096968|3717|; LRP5|IDBG-61383|ENSG00000162337|4041|; LRP6|IDBG-20075|ENSG00000070018|4040|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; PPM1A|IDBG-8210|ENSG00000100614|5494|; RALB|IDBG-68212|ENSG00000144118|5899|; SHC1|IDBG-103007|ENSG00000160691|6464|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; SP1|IDBG-36616|ENSG00000185591|6667|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; UBC|IDBG-64029|ENSG00000150991|7316|; WWOX|IDBG-43129|ENSG00000186153|51741|; YWHAE|IDBG-14629|ENSG00000108953|7531|; 
Pdgf signaling pathway	4071	PID BIOCARTA	9606	2	26	0.04181904440177722	0.07584826680714496	CSNK2A1; SHC1; 	CSNK2A1|IDBG-37787|ENSG00000101266|1457|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Class I MHC mediated antigen processing & presentation	19282	REACTOME	9606	7	256	0.042276144422186426	0.07642755750590706	CUL3; DZIP3; FBXO6; HUWE1; UBC; UBE3A; VHL; 	CUL3|IDBG-82331|ENSG00000036257|8452|; DZIP3|IDBG-49039|ENSG00000198919|9666|; FBXO6|IDBG-89462|ENSG00000116663|26270|; HUWE1|IDBG-70116|ENSG00000086758|10075|; UBC|IDBG-64029|ENSG00000150991|7316|; UBE3A|IDBG-4274|ENSG00000114062|7337|; VHL|IDBG-17819|ENSG00000134086|7428|; 
Control of gene expression by vitamin d receptor	4029	PID BIOCARTA	9606	2	27	0.04480121165711706	0.0794398481460063	EP300; NCOR1; 	EP300|IDBG-8992|ENSG00000100393|2033|; NCOR1|IDBG-31971|ENSG00000141027|9611|; 
GRB2 events in ERBB2 signaling	13287	REACTOME	9606	2	27	0.04480121165711706	0.0794398481460063	EGFR; JAK2; 	EGFR|IDBG-16933|ENSG00000146648|1956|; JAK2|IDBG-47039|ENSG00000096968|3717|; 
Interleukin receptor SHC signaling	13081	REACTOME	9606	2	27	0.04480121165711706	0.0794398481460063	JAK2; SHC1; 	JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
mTOR signalling	13277	REACTOME	9606	2	27	0.04480121165711706	0.0794398481460063	AKT2; PPM1A; 	AKT2|IDBG-51270|ENSG00000105221|208|; PPM1A|IDBG-8210|ENSG00000100614|5494|; 
BCR signaling pathway	15384	PID NCI	9606	3	63	0.044571590788127086	0.08005576986217001	CSNK2A1; MAP3K7; SHC1; 	CSNK2A1|IDBG-37787|ENSG00000101266|1457|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Colorectal cancer	442	KEGG	9606	3	63	0.044571590788127086	0.08005576986217001	AKT2; SMAD2; SMAD3; 	AKT2|IDBG-51270|ENSG00000105221|208|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; 
Mitotic Prophase	18847	REACTOME	9606	4	107	0.04558333096025116	0.08005933127512467	CCNB2; HIST2H2AC; HIST2H2BE; HIST3H3; 	CCNB2|IDBG-14456|ENSG00000157456|9133|; HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; 
Signaling by Insulin receptor	13281	REACTOME	9606	4	107	0.04558333096025116	0.08005933127512467	AKT2; JAK2; PPM1A; SHC1; 	AKT2|IDBG-51270|ENSG00000105221|208|; JAK2|IDBG-47039|ENSG00000096968|3717|; PPM1A|IDBG-8210|ENSG00000100614|5494|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Apoptosis	17979	REACTOME	9606	5	155	0.04552623708099526	0.08046834898074003	AKT2; KPNB1; UBC; YWHAE; YWHAQ; 	AKT2|IDBG-51270|ENSG00000105221|208|; KPNB1|IDBG-56053|ENSG00000108424|3837|; UBC|IDBG-64029|ENSG00000150991|7316|; YWHAE|IDBG-14629|ENSG00000108953|7531|; YWHAQ|IDBG-27933|ENSG00000134308|10971|; 
E2F transcription factor network	15410	PID NCI	9606	3	64	0.04634872359830993	0.0811468189181767	E2F7; SIRT1; SP1; 	E2F7|IDBG-49113|ENSG00000165891|144455|; SIRT1|IDBG-75847|ENSG00000096717|23411|; SP1|IDBG-36616|ENSG00000185591|6667|; 
ErbB2/ErbB3 signaling events	15442	PID NCI	9606	2	28	0.047859701408775164	0.0827480818749851	JAK2; SHC1; 	JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
IL2 signaling events mediated by STAT5	15584	PID NCI	9606	2	28	0.047859701408775164	0.0827480818749851	SHC1; SP1; 	SHC1|IDBG-103007|ENSG00000160691|6464|; SP1|IDBG-36616|ENSG00000185591|6667|; 
PKB-mediated events	16929	REACTOME	9606	2	28	0.047859701408775164	0.0827480818749851	AKT2; PPM1A; 	AKT2|IDBG-51270|ENSG00000105221|208|; PPM1A|IDBG-8210|ENSG00000100614|5494|; 
Thromboxane A2 receptor signaling	14941	PID NCI	9606	2	28	0.047859701408775164	0.0827480818749851	EGFR; ICAM1; 	EGFR|IDBG-16933|ENSG00000146648|1956|; ICAM1|IDBG-26804|ENSG00000090339|3383|; 
L1CAM interactions	13877	REACTOME	9606	4	109	0.04822589156287151	0.083122266513645	CSNK2A1; DPYSL2; EGFR; TUBA4A; 	CSNK2A1|IDBG-37787|ENSG00000101266|1457|; DPYSL2|IDBG-13200|ENSG00000092964|102723812,1808|; EGFR|IDBG-16933|ENSG00000146648|1956|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; 
Interferon Signaling	18059	REACTOME	9606	5	158	0.048730159865604555	0.08373138924275705	ARIH1; ICAM1; JAK2; KPNB1; UBC; 	ARIH1|IDBG-20750|ENSG00000166233|25820|; ICAM1|IDBG-26804|ENSG00000090339|3383|; JAK2|IDBG-47039|ENSG00000096968|3717|; KPNB1|IDBG-56053|ENSG00000108424|3837|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Glioma	523	KEGG	9606	3	66	0.05000684247212295	0.08565986904946987	AKT2; EGFR; SHC1; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
IGF1 pathway	15262	PID NCI	9606	2	29	0.050992160053026966	0.08654632669550448	SHC1; YWHAE; 	SHC1|IDBG-103007|ENSG00000160691|6464|; YWHAE|IDBG-14629|ENSG00000108953|7531|; 
Internalization of ErbB1	15162	PID NCI	9606	2	29	0.050992160053026966	0.08654632669550448	EGFR; SHC1; 	EGFR|IDBG-16933|ENSG00000146648|1956|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Lissencephaly gene (LIS1) in neuronal migration and development	15729	PID NCI	9606	2	29	0.050992160053026966	0.08654632669550448	CSNK2A1; YWHAE; 	CSNK2A1|IDBG-37787|ENSG00000101266|1457|; YWHAE|IDBG-14629|ENSG00000108953|7531|; 
Assembly of the pre-replicative complex	12961	REACTOME	9606	3	67	0.051887335644205355	0.08753030784964734	GMNN; MCM2; UBC; 	GMNN|IDBG-65780|ENSG00000112312|51053|; MCM2|IDBG-54871|ENSG00000073111|4171|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Cytosolic sensors of pathogen-associated DNA 	19557	REACTOME	9606	3	67	0.051887335644205355	0.08753030784964734	APP; EP300; UBC; 	APP|IDBG-1100|ENSG00000142192|351|; EP300|IDBG-8992|ENSG00000100393|2033|; UBC|IDBG-64029|ENSG00000150991|7316|; 
TSLP	15928	NETPATH	9606	5	161	0.052064705180140135	0.08756336780296296	CHD8; JAK2; RPAP1; SHC1; WDR36; 	CHD8|IDBG-2645|ENSG00000100888|57680|; JAK2|IDBG-47039|ENSG00000096968|3717|; RPAP1|IDBG-7174|ENSG00000103932|102724088,26015|; SHC1|IDBG-103007|ENSG00000160691|6464|; WDR36|IDBG-36607|ENSG00000134987|134430|; 
BMP receptor signaling	15033	PID NCI	9606	2	30	0.05419628020682381	0.0892550015275585	MAP3K7; PPM1A; 	MAP3K7|IDBG-94374|ENSG00000135341|6885|; PPM1A|IDBG-8210|ENSG00000100614|5494|; 
Circadian rhythm	526	KEGG	9606	2	30	0.05419628020682381	0.0892550015275585	CRY2; CSNK1E; 	CRY2|IDBG-41167|ENSG00000121671|1408|; CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; 
EPO signaling pathway	15297	PID NCI	9606	2	30	0.05419628020682381	0.0892550015275585	JAK2; SHC1; 	JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Oncogene Induced Senescence	16811	REACTOME	9606	2	30	0.05419628020682381	0.0892550015275585	SP1; UBC; 	SP1|IDBG-36616|ENSG00000185591|6667|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Antiviral mechanism by IFN-stimulated genes	17226	REACTOME	9606	3	68	0.05380177235575156	0.08966962059291926	ARIH1; KPNB1; UBC; 	ARIH1|IDBG-20750|ENSG00000166233|25820|; KPNB1|IDBG-56053|ENSG00000108424|3837|; UBC|IDBG-64029|ENSG00000150991|7316|; 
ISG15 antiviral mechanism	13075	REACTOME	9606	3	68	0.05380177235575156	0.08966962059291926	ARIH1; KPNB1; UBC; 	ARIH1|IDBG-20750|ENSG00000166233|25820|; KPNB1|IDBG-56053|ENSG00000108424|3837|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Renal cell carcinoma	483	KEGG	9606	3	68	0.05380177235575156	0.08966962059291926	AKT2; EP300; VHL; 	AKT2|IDBG-51270|ENSG00000105221|208|; EP300|IDBG-8992|ENSG00000100393|2033|; VHL|IDBG-17819|ENSG00000134086|7428|; 
Oocyte meiosis	8113	KEGG	9606	4	114	0.055196800475586796	0.0906337995974872	AR; CCNB2; YWHAE; YWHAQ; 	AR|IDBG-73722|ENSG00000169083|367|; CCNB2|IDBG-14456|ENSG00000157456|9133|; YWHAE|IDBG-14629|ENSG00000108953|7531|; YWHAQ|IDBG-27933|ENSG00000134308|10971|; 
Signaling by EGFR	13216	REACTOME	9606	5	164	0.055530123748454015	0.09091214949968136	AKT2; EGFR; JAK2; SHC1; UBC; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Bcr signaling pathway	4023	PID BIOCARTA	9606	2	31	0.0574697999460226	0.0932623946492472	CSNK2A1; SHC1; 	CSNK2A1|IDBG-37787|ENSG00000101266|1457|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
IL1-mediated signaling events	15122	PID NCI	9606	2	31	0.0574697999460226	0.0932623946492472	MAP3K7; TAB1; 	MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; 
disassembly of the destruction complex and recruitment of AXIN to the membrane	17567	REACTOME	9606	2	31	0.0574697999460226	0.0932623946492472	LRP5; LRP6; 	LRP5|IDBG-61383|ENSG00000162337|4041|; LRP6|IDBG-20075|ENSG00000070018|4040|; 
IL1	15917	NETPATH	9606	3	70	0.0577313817671464	0.09341375183896866	EIF2AK3; MAP3K7; TAB1; 	EIF2AK3|IDBG-60518|ENSG00000172071|9451|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; 
Signaling by EGFR in Cancer	16839	REACTOME	9606	5	166	0.05791314919204283	0.09343545872553422	AKT2; EGFR; JAK2; SHC1; UBC; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Leishmaniasis	10355	KEGG	9606	3	71	0.05974598450789333	0.09611310551269796	JAK2; MAP3K7; TAB1; 	JAK2|IDBG-47039|ENSG00000096968|3717|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; 
Role of egf receptor transactivation by gpcrs in cardiac hypertrophy	3987	PID BIOCARTA	9606	2	32	0.06081050203759795	0.09726175397944341	EGFR; SHC1; 	EGFR|IDBG-16933|ENSG00000146648|1956|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Signaling by NOTCH2	18259	REACTOME	9606	2	32	0.06081050203759795	0.09726175397944341	EP300; UBC; 	EP300|IDBG-8992|ENSG00000100393|2033|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Wnt	15912	NETPATH	9606	4	118	0.06114581274626174	0.0975170289487795	CSNK1E; LRP5; LRP6; MAP3K7; 	CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; LRP5|IDBG-61383|ENSG00000162337|4041|; LRP6|IDBG-20075|ENSG00000070018|4040|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; 
Removal of licensing factors from origins	12932	REACTOME	9606	3	72	0.061793391653114364	0.09826742798704433	GMNN; MCM2; UBC; 	GMNN|IDBG-65780|ENSG00000112312|51053|; MCM2|IDBG-54871|ENSG00000073111|4171|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Toxoplasmosis	10385	KEGG	9606	4	119	0.06268432653233222	0.09939943207269823	AKT2; JAK2; MAP3K7; TAB1; 	AKT2|IDBG-51270|ENSG00000105221|208|; JAK2|IDBG-47039|ENSG00000096968|3717|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; 
Mitotic Prometaphase	12940	REACTOME	9606	4	120	0.06424321390533941	0.10043657385200949	CCNB2; CSNK2A1; MIS12; TUBA4A; 	CCNB2|IDBG-14456|ENSG00000157456|9133|; CSNK2A1|IDBG-37787|ENSG00000101266|1457|; MIS12|IDBG-21731|ENSG00000167842|79003|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; 
Alpha4 beta1 integrin signaling events	15573	PID NCI	9606	2	33	0.06421621318691614	0.10067796135236853	CD81; IGSF8; 	CD81|IDBG-22455|ENSG00000110651|975|; IGSF8|IDBG-103984|ENSG00000162729|93185|; 
Bioactive peptide induced signaling pathway	4135	PID BIOCARTA	9606	2	33	0.06421621318691614	0.10067796135236853	JAK2; SHC1; 	JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Integrin signaling pathway	4024	PID BIOCARTA	9606	2	33	0.06421621318691614	0.10067796135236853	ACTA1; SHC1; 	ACTA1|IDBG-107311|ENSG00000143632|58|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Negative regulators of RIG-I/MDA5 signaling	13013	REACTOME	9606	2	33	0.06421621318691614	0.10067796135236853	CYLD; UBC; 	CYLD|IDBG-30697|ENSG00000083799|102724054,1540|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Chronic myeloid leukemia	582	KEGG	9606	3	74	0.06598538795694064	0.10287047841601701	AKT2; SHC1; SMAD3; 	AKT2|IDBG-51270|ENSG00000105221|208|; SHC1|IDBG-103007|ENSG00000160691|6464|; SMAD3|IDBG-18366|ENSG00000166949|4088|; 
Angiotensin ii mediated activation of jnk pathway via pyk2 dependent signaling	4049	PID BIOCARTA	9606	2	34	0.06768480330185955	0.10463806638588315	EGFR; SHC1; 	EGFR|IDBG-16933|ENSG00000146648|1956|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Trefoil factors initiate mucosal healing	4063	PID BIOCARTA	9606	2	34	0.06768480330185955	0.10463806638588315	EGFR; SHC1; 	EGFR|IDBG-16933|ENSG00000146648|1956|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription	19264	REACTOME	9606	4	122	0.06742181490189958	0.10481542652816321	CHD3; CHD4; HIST2H2AC; HIST2H2BE; 	CHD3|IDBG-27053|ENSG00000170004|1107|; CHD4|IDBG-14532|ENSG00000111642|1108|; HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; 
Regulation of DNA replication	19523	REACTOME	9606	3	75	0.06812934266158946	0.10503273660328376	GMNN; MCM2; UBC; 	GMNN|IDBG-65780|ENSG00000112312|51053|; MCM2|IDBG-54871|ENSG00000073111|4171|; UBC|IDBG-64029|ENSG00000150991|7316|; 
IRS-mediated signalling	18112	REACTOME	9606	3	76	0.07030483356954012	0.10808637847948689	AKT2; JAK2; PPM1A; 	AKT2|IDBG-51270|ENSG00000105221|208|; JAK2|IDBG-47039|ENSG00000096968|3717|; PPM1A|IDBG-8210|ENSG00000100614|5494|; 
Signal transduction through il1r	4064	PID BIOCARTA	9606	2	35	0.07121418476849906	0.1082845823192246	MAP3K7; TAB1; 	MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; 
TWEAK	15930	NETPATH	9606	2	35	0.07121418476849906	0.1082845823192246	AKT2; MAP3K7; 	AKT2|IDBG-51270|ENSG00000105221|208|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; 
Toll-like receptor pathway	3951	PID BIOCARTA	9606	2	35	0.07121418476849906	0.1082845823192246	MAP3K7; TAB1; 	MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; 
Validated transcriptional targets of AP1 family members Fra1 and Fra2	14994	PID NCI	9606	2	35	0.07121418476849906	0.1082845823192246	EP300; SP1; 	EP300|IDBG-8992|ENSG00000100393|2033|; SP1|IDBG-36616|ENSG00000185591|6667|; 
IGF1 signaling pathway	16216	INOH	9606	2	36	0.07480231172261946	0.11281326903818967	AKT2; SHC1; 	AKT2|IDBG-51270|ENSG00000105221|208|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
TNF receptor signaling pathway	15154	PID NCI	9606	2	36	0.07480231172261946	0.11281326903818967	CYLD; MAP3K7; 	CYLD|IDBG-30697|ENSG00000083799|102724054,1540|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; 
C-MYB transcription factor network	15398	PID NCI	9606	3	78	0.07474907968303575	0.11334901427345585	MAP3K7; NCOR1; SP1; 	MAP3K7|IDBG-94374|ENSG00000135341|6885|; NCOR1|IDBG-31971|ENSG00000141027|9611|; SP1|IDBG-36616|ENSG00000185591|6667|; 
IRS-related events	18844	REACTOME	9606	3	79	0.07701714729794809	0.11583879878146665	AKT2; JAK2; PPM1A; 	AKT2|IDBG-51270|ENSG00000105221|208|; JAK2|IDBG-47039|ENSG00000096968|3717|; PPM1A|IDBG-8210|ENSG00000100614|5494|; 
Cysteine and methionine metabolism	4362	KEGG	9606	2	38	0.08214682323699335	0.11600887251025778	AHCYL1; AHCYL2; 	AHCYL1|IDBG-100935|ENSG00000168710|10768|; AHCYL2|IDBG-40716|ENSG00000158467|23382|; 
FOXA2 and FOXA3 transcription factor networks	14900	PID NCI	9606	2	38	0.08214682323699335	0.11600887251025778	FOXA1; SP1; 	FOXA1|IDBG-5104|ENSG00000129514|3169|; SP1|IDBG-36616|ENSG00000185591|6667|; 
Inactivation of gsk3 by akt causes accumulation of b-catenin in alveolar macrophages	4022	PID BIOCARTA	9606	2	38	0.08214682323699335	0.11600887251025778	CSNK2A1; LRP6; 	CSNK2A1|IDBG-37787|ENSG00000101266|1457|; LRP6|IDBG-20075|ENSG00000070018|4040|; 
AMER1 mutants destabilize the destruction complex	16848	REACTOME	9606	3	81	0.08164340971496993	0.11618485228668798	TLE1; TLE2; UBC; 	TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
APC truncation mutants are not K63 polyubiquitinated	16833	REACTOME	9606	3	81	0.08164340971496993	0.11618485228668798	TLE1; TLE2; UBC; 	TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
APC truncation mutants have impaired AXIN binding	17628	REACTOME	9606	3	81	0.08164340971496993	0.11618485228668798	TLE1; TLE2; UBC; 	TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
AXIN missense mutants destabilize the destruction complex	17110	REACTOME	9606	3	81	0.08164340971496993	0.11618485228668798	TLE1; TLE2; UBC; 	TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
AXIN mutants destabilize the destruction complex, activating WNT signaling	16826	REACTOME	9606	3	81	0.08164340971496993	0.11618485228668798	TLE1; TLE2; UBC; 	TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Degradation of beta-catenin by the destruction complex	13328	REACTOME	9606	3	81	0.08164340971496993	0.11618485228668798	TLE1; TLE2; UBC; 	TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
S33 mutants of beta-catenin aren't phosphorylated	18561	REACTOME	9606	3	81	0.08164340971496993	0.11618485228668798	TLE1; TLE2; UBC; 	TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
S37 mutants of beta-catenin aren't phosphorylated	19772	REACTOME	9606	3	81	0.08164340971496993	0.11618485228668798	TLE1; TLE2; UBC; 	TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
S45 mutants of beta-catenin aren't phosphorylated	18114	REACTOME	9606	3	81	0.08164340971496993	0.11618485228668798	TLE1; TLE2; UBC; 	TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
T41 mutants of beta-catenin aren't phosphorylated	17841	REACTOME	9606	3	81	0.08164340971496993	0.11618485228668798	TLE1; TLE2; UBC; 	TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
TCF7L2 mutants don't bind CTBP	19152	REACTOME	9606	3	81	0.08164340971496993	0.11618485228668798	TLE1; TLE2; UBC; 	TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
deletions in the AMER1 gene destabilize the destruction complex	18145	REACTOME	9606	3	81	0.08164340971496993	0.11618485228668798	TLE1; TLE2; UBC; 	TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
deletions in the AXIN genes in hepatocellular carcinoma result in elevated WNT signaling	19027	REACTOME	9606	3	81	0.08164340971496993	0.11618485228668798	TLE1; TLE2; UBC; 	TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
misspliced GSK3beta mutants stabilize beta-catenin	18097	REACTOME	9606	3	81	0.08164340971496993	0.11618485228668798	TLE1; TLE2; UBC; 	TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex	18661	REACTOME	9606	3	81	0.08164340971496993	0.11618485228668798	TLE1; TLE2; UBC; 	TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
truncated APC mutants destabilize the destruction complex	16689	REACTOME	9606	3	81	0.08164340971496993	0.11618485228668798	TLE1; TLE2; UBC; 	TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
truncations of AMER1 destabilize the destruction complex	18627	REACTOME	9606	3	81	0.08164340971496993	0.11618485228668798	TLE1; TLE2; UBC; 	TLE1|IDBG-73128|ENSG00000196781|7088|; TLE2|IDBG-16680|ENSG00000065717|7089|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Metabolism of proteins	18366	REACTOME	9606	13	678	0.08302008054641005	0.11694452970369944	CCT2; CCT3; CCT4; CCT5; CCT6A; CCT7; EIF1AX; EIF2AK3; FBXO6; RPS4Y1; SHC1; TCP1; TUBA4A; 	CCT2|IDBG-47181|ENSG00000166226|10576|; CCT3|IDBG-103469|ENSG00000163468|7203|; CCT4|IDBG-53426|ENSG00000115484|10575|; CCT5|IDBG-12328|ENSG00000150753|22948|; CCT6A|IDBG-17442|ENSG00000146731|908|; CCT7|IDBG-56424|ENSG00000135624|10574|; EIF1AX|IDBG-50658|ENSG00000173674|1964|; EIF2AK3|IDBG-60518|ENSG00000172071|9451|; FBXO6|IDBG-89462|ENSG00000116663|26270|; RPS4Y1|IDBG-6|ENSG00000129824|6192|; SHC1|IDBG-103007|ENSG00000160691|6464|; TCP1|IDBG-98570|ENSG00000120438|677812,6950|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; 
ATR signaling pathway	15654	PID NCI	9606	2	37	0.07844717936050263	0.11767076904075395	MCM2; RAD51; 	MCM2|IDBG-54871|ENSG00000073111|4171|; RAD51|IDBG-6509|ENSG00000051180|5888|; 
p75 NTR receptor-mediated signalling	17826	REACTOME	9606	3	82	0.084000883851079	0.11802655832240214	HDAC3; UBC; YWHAE; 	HDAC3|IDBG-50725|ENSG00000171720|8841|; UBC|IDBG-64029|ENSG00000150991|7316|; YWHAE|IDBG-14629|ENSG00000108953|7531|; 
IRS-related events triggered by IGF1R	13282	REACTOME	9606	3	80	0.07931537657675428	0.11833342473144791	AKT2; JAK2; PPM1A; 	AKT2|IDBG-51270|ENSG00000105221|208|; JAK2|IDBG-47039|ENSG00000096968|3717|; PPM1A|IDBG-8210|ENSG00000100614|5494|; 
Direct p53 effectors	15209	PID NCI	9606	4	129	0.07917673156343932	0.11844497578897258	EGFR; FOXA1; PCNA; SP1; 	EGFR|IDBG-16933|ENSG00000146648|1956|; FOXA1|IDBG-5104|ENSG00000129514|3169|; PCNA|IDBG-50801|ENSG00000132646|5111|; SP1|IDBG-36616|ENSG00000185591|6667|; 
VEGF signaling pathway	16190	INOH	9606	5	183	0.0805054940653194	0.11978699519102486	AKT2; CSNK1E; EGFR; JAK2; MAP3K7; 	AKT2|IDBG-51270|ENSG00000105221|208|; CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; EGFR|IDBG-16933|ENSG00000146648|1956|; JAK2|IDBG-47039|ENSG00000096968|3717|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; 
Nuclear Receptor transcription pathway	13739	REACTOME	9606	2	39	0.085899318569282	0.12008594913337912	AR; ESR1; 	AR|IDBG-73722|ENSG00000169083|367|; ESR1|IDBG-97997|ENSG00000091831|2099|; 
RNA Polymerase I Promoter Opening	13737	REACTOME	9606	2	39	0.085899318569282	0.12008594913337912	HIST2H2AC; HIST2H2BE; 	HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; 
Osteoclast differentiation	10367	KEGG	9606	4	133	0.08632441462269048	0.12037701034068649	AKT2; CYLD; MAP3K7; TAB1; 	AKT2|IDBG-51270|ENSG00000105221|208|; CYLD|IDBG-30697|ENSG00000083799|102724054,1540|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; 
IL3	15919	NETPATH	9606	3	84	0.08880268014493996	0.12290645256968	JAK2; SHC1; YWHAQ; 	JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; YWHAQ|IDBG-27933|ENSG00000134308|10971|; 
Negative epigenetic regulation of rRNA expression	19850	REACTOME	9606	3	84	0.08880268014493996	0.12290645256968	HIST2H2AC; HIST2H2BE; SIRT1; 	HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; SIRT1|IDBG-75847|ENSG00000096717|23411|; 
Senescence-Associated Secretory Phenotype (SASP)	19271	REACTOME	9606	3	84	0.08880268014493996	0.12290645256968	HIST2H2AC; HIST2H2BE; UBC; 	HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; UBC|IDBG-64029|ENSG00000150991|7316|; 
IL-1 signaling pathway 	16110	INOH	9606	2	40	0.08970277958841533	0.1238433897302749	MAP3K7; TAB1; 	MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; 
Hepatitis C	10404	KEGG	9606	4	136	0.09188523699149378	0.12654170354907954	AKT2; CD81; EGFR; EIF2AK3; 	AKT2|IDBG-51270|ENSG00000105221|208|; CD81|IDBG-22455|ENSG00000110651|975|; EGFR|IDBG-16933|ENSG00000146648|1956|; EIF2AK3|IDBG-60518|ENSG00000172071|9451|; 
NGF signalling via TRKA from the plasma membrane	18753	REACTOME	9606	5	191	0.092559723083727	0.12715506512739724	AKT2; EGFR; JAK2; RALB; SHC1; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; JAK2|IDBG-47039|ENSG00000096968|3717|; RALB|IDBG-68212|ENSG00000144118|5899|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
DNA methylation	18620	REACTOME	9606	2	41	0.0935553588591829	0.12788971469666627	HIST2H2AC; HIST2H2BE; 	HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; 
Recycling pathway of L1	13874	REACTOME	9606	2	41	0.0935553588591829	0.12788971469666627	DPYSL2; TUBA4A; 	DPYSL2|IDBG-13200|ENSG00000092964|102723812,1808|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; 
Insulin Pathway	15835	PID NCI	9606	2	42	0.09745524662656317	0.13256779871995725	AKT2; SHC1; 	AKT2|IDBG-51270|ENSG00000105221|208|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Toll-like receptor signaling pathway 	16121	INOH	9606	2	42	0.09745524662656317	0.13256779871995725	MAP3K7; TAB1; 	MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; 
G2/M Checkpoints	17760	REACTOME	9606	2	43	0.10140067019143853	0.1369279123023075	CCNB2; MCM2; 	CCNB2|IDBG-14456|ENSG00000157456|9133|; MCM2|IDBG-54871|ENSG00000073111|4171|; 
PDGF signaling pathway	16259	INOH	9606	2	43	0.10140067019143853	0.1369279123023075	AKT2; SHC1; 	AKT2|IDBG-51270|ENSG00000105221|208|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
ErbB signaling pathway	461	KEGG	9606	3	89	0.10129613987774103	0.13745564213238695	AKT2; EGFR; SHC1; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Gap junction	436	KEGG	9606	3	90	0.10387556499276085	0.13992946255092784	EGFR; TUBA4A; TUBB8; 	EGFR|IDBG-16933|ENSG00000146648|1956|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; TUBB8|IDBG-777287|ENSG00000261456|347688|; 
MAPK signaling pathway	487	KEGG	9606	6	257	0.10466256705673681	0.14064824386559063	AKT2; CACNB3; EGFR; MAP3K7; PPM1A; TAB1; 	AKT2|IDBG-51270|ENSG00000105221|208|; CACNB3|IDBG-30418|ENSG00000167535|784|; EGFR|IDBG-16933|ENSG00000146648|1956|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; PPM1A|IDBG-8210|ENSG00000100614|5494|; TAB1|IDBG-8281|ENSG00000100324|10454|; 
Downstream TCR signaling	13068	REACTOME	9606	2	44	0.10538989325323682	0.14094311025432876	MAP3K7; UBC; 	MAP3K7|IDBG-94374|ENSG00000135341|6885|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Nfat and hypertrophy of the heart 	4058	PID BIOCARTA	9606	2	44	0.10538989325323682	0.14094311025432876	ACTA1; SHC1; 	ACTA1|IDBG-107311|ENSG00000143632|58|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
TCR	15915	NETPATH	9606	6	259	0.10757224086084133	0.14351585018693977	ACTA1; DNAJB1; DPYSL2; SHC1; TUBA4A; YWHAQ; 	ACTA1|IDBG-107311|ENSG00000143632|58|; DNAJB1|IDBG-33491|ENSG00000132002|3337|; DPYSL2|IDBG-13200|ENSG00000092964|102723812,1808|; SHC1|IDBG-103007|ENSG00000160691|6464|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; YWHAQ|IDBG-27933|ENSG00000134308|10971|; 
Signaling by FGFR	13320	REACTOME	9606	4	145	0.10955944189225039	0.14546768002439944	AKT2; EGFR; JAK2; UBC; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; JAK2|IDBG-47039|ENSG00000096968|3717|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Interleukin-2 signaling	13083	REACTOME	9606	2	45	0.10942121530870082	0.14563255274899028	JAK2; SHC1; 	JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
RNA Polymerase I Transcription Initiation	13738	REACTOME	9606	2	46	0.11349297102596073	0.15033078501052077	CHD3; CHD4; 	CHD3|IDBG-27053|ENSG00000170004|1107|; CHD4|IDBG-14532|ENSG00000111642|1108|; 
Nucleotide excision repair	2801	KEGG	9606	2	47	0.11760352964208978	0.15540466416990434	CUL4A; PCNA; 	CUL4A|IDBG-52956|ENSG00000139842|8451|; PCNA|IDBG-50801|ENSG00000132646|5111|; 
Membrane Trafficking	19875	REACTOME	9606	5	207	0.11927374535688642	0.15723736026857948	AKT2; TUBA4A; UBC; YWHAE; YWHAQ; 	AKT2|IDBG-51270|ENSG00000105221|208|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; UBC|IDBG-64029|ENSG00000150991|7316|; YWHAE|IDBG-14629|ENSG00000108953|7531|; YWHAQ|IDBG-27933|ENSG00000134308|10971|; 
Formation of the ternary complex, and subsequently, the 43S complex	13448	REACTOME	9606	2	48	0.12175129438457724	0.15974460610742405	EIF1AX; RPS4Y1; 	EIF1AX|IDBG-50658|ENSG00000173674|1964|; RPS4Y1|IDBG-6|ENSG00000129824|6192|; 
Notch signaling pathway	491	KEGG	9606	2	48	0.12175129438457724	0.15974460610742405	EP300; NCOR2; 	EP300|IDBG-8992|ENSG00000100393|2033|; NCOR2|IDBG-63911|ENSG00000196498|9612|; 
Deposition of new CENPA-containing nucleosomes at the centromere	12912	REACTOME	9606	2	49	0.1259347018631928	0.16368561951773306	HIST2H2AC; HIST2H2BE; 	HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; 
Il-2 receptor beta chain in t cell activation	4011	PID BIOCARTA	9606	2	49	0.1259347018631928	0.16368561951773306	PCNA; SHC1; 	PCNA|IDBG-50801|ENSG00000132646|5111|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Malaria	10359	KEGG	9606	2	49	0.1259347018631928	0.16368561951773306	CD81; ICAM1; 	CD81|IDBG-22455|ENSG00000110651|975|; ICAM1|IDBG-26804|ENSG00000090339|3383|; 
Nucleosome assembly	17736	REACTOME	9606	2	49	0.1259347018631928	0.16368561951773306	HIST2H2AC; HIST2H2BE; 	HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; 
CXCR4-mediated signaling events	15059	PID NCI	9606	2	50	0.13015222151323091	0.1683787481115225	JAK2; RALB; 	JAK2|IDBG-47039|ENSG00000096968|3717|; RALB|IDBG-68212|ENSG00000144118|5899|; 
Axon guidance	17789	REACTOME	9606	7	336	0.13004639301892845	0.1686349255268815	CACNB3; CSNK2A1; DPYSL2; DPYSL5; EGFR; JAK2; TUBA4A; 	CACNB3|IDBG-30418|ENSG00000167535|784|; CSNK2A1|IDBG-37787|ENSG00000101266|1457|; DPYSL2|IDBG-13200|ENSG00000092964|102723812,1808|; DPYSL5|IDBG-36183|ENSG00000157851|56896|; EGFR|IDBG-16933|ENSG00000146648|1956|; JAK2|IDBG-47039|ENSG00000096968|3717|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; 
Downstream signaling events of B Cell Receptor (BCR)	19698	REACTOME	9606	4	155	0.1308404251517406	0.16887543246329312	AKT2; EGFR; MAP3K7; UBC; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; UBC|IDBG-64029|ENSG00000150991|7316|; 
BCR	15916	NETPATH	9606	4	157	0.13529075647479857	0.1742143151821652	CD81; HNRNPK; MAP3K7; SHC1; 	CD81|IDBG-22455|ENSG00000110651|975|; HNRNPK|IDBG-73948|ENSG00000165119|3190|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Signaling events mediated by Stem cell factor receptor (c-Kit)	15404	PID NCI	9606	2	52	0.13868363576336923	0.17816994872377298	JAK2; SHC1; 	JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Chagas disease (American trypanosomiasis)	10366	KEGG	9606	3	103	0.13962655363236282	0.17855469416120132	AKT2; SMAD2; SMAD3; 	AKT2|IDBG-51270|ENSG00000105221|208|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; 
Toll-like receptor signaling pathway	564	KEGG	9606	3	103	0.13962655363236282	0.17855469416120132	AKT2; MAP3K7; TAB1; 	AKT2|IDBG-51270|ENSG00000105221|208|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; 
Platelet activation, signaling and aggregation	17662	REACTOME	9606	5	219	0.14144710152321058	0.18046699159857904	AKT2; APP; JAK2; SHC1; TUBA4A; 	AKT2|IDBG-51270|ENSG00000105221|208|; APP|IDBG-1100|ENSG00000142192|351|; JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; 
Caspase Cascade in Apoptosis	14995	PID NCI	9606	2	53	0.142994628265771	0.18077908584852598	ACTA1; APP; 	ACTA1|IDBG-107311|ENSG00000143632|58|; APP|IDBG-1100|ENSG00000142192|351|; 
Endometrial cancer	506	KEGG	9606	2	53	0.142994628265771	0.18077908584852598	AKT2; EGFR; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; 
Notch signaling pathway	15899	PID NCI	9606	2	53	0.142994628265771	0.18077908584852598	EP300; LNX1; 	EP300|IDBG-8992|ENSG00000100393|2033|; LNX1|IDBG-18546|ENSG00000072201|84708|; 
KitReceptor	15910	NETPATH	9606	3	104	0.14253299698356384	0.18143535166485764	EP300; JAK2; SHC1; 	EP300|IDBG-8992|ENSG00000100393|2033|; JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Orphan transporters	18365	REACTOME	9606	3	105	0.1454597209399846	0.1834776025492988	NCOA6; TBL1X; TBL1XR1; 	NCOA6|IDBG-68724|ENSG00000198646|23054|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; 
Signaling by FGFR in disease	16656	REACTOME	9606	4	162	0.1466826775243779	0.18460064858510147	AKT2; EGFR; JAK2; UBC; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; JAK2|IDBG-47039|ENSG00000096968|3717|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Ribosomal scanning and start codon recognition	13450	REACTOME	9606	2	55	0.15170015915685753	0.1900532467992233	EIF1AX; RPS4Y1; 	EIF1AX|IDBG-50658|ENSG00000173674|1964|; RPS4Y1|IDBG-6|ENSG00000129824|6192|; 
Translation initiation complex formation	13445	REACTOME	9606	2	55	0.15170015915685753	0.1900532467992233	EIF1AX; RPS4Y1; 	EIF1AX|IDBG-50658|ENSG00000173674|1964|; RPS4Y1|IDBG-6|ENSG00000129824|6192|; 
Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S	13446	REACTOME	9606	2	56	0.1560919774995571	0.19424001684361927	EIF1AX; RPS4Y1; 	EIF1AX|IDBG-50658|ENSG00000173674|1964|; RPS4Y1|IDBG-6|ENSG00000129824|6192|; 
Mapkinase signaling pathway	4137	PID BIOCARTA	9606	2	56	0.1560919774995571	0.19424001684361927	MAP3K7; SP1; 	MAP3K7|IDBG-94374|ENSG00000135341|6885|; SP1|IDBG-36616|ENSG00000185591|6667|; 
degradation of DVL	17694	REACTOME	9606	2	56	0.1560919774995571	0.19424001684361927	CUL3; UBC; 	CUL3|IDBG-82331|ENSG00000036257|8452|; UBC|IDBG-64029|ENSG00000150991|7316|; 
NOD-like receptor signaling pathway	8112	KEGG	9606	2	57	0.16050806647926247	0.19884369842855062	MAP3K7; TAB1; 	MAP3K7|IDBG-94374|ENSG00000135341|6885|; TAB1|IDBG-8281|ENSG00000100324|10454|; 
Non-small cell lung cancer	444	KEGG	9606	2	57	0.16050806647926247	0.19884369842855062	AKT2; EGFR; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; 
mRNA Splicing	19346	REACTOME	9606	3	111	0.1634228760732281	0.20155488049031467	HNRNPF; HNRNPK; RBMX; 	HNRNPF|IDBG-71348|ENSG00000169813|3185|; HNRNPK|IDBG-73948|ENSG00000165119|3190|; RBMX|IDBG-87732|ENSG00000147274|101928747,26787,27316|; 
mRNA Splicing - Major Pathway	13745	REACTOME	9606	3	111	0.1634228760732281	0.20155488049031467	HNRNPF; HNRNPK; RBMX; 	HNRNPF|IDBG-71348|ENSG00000169813|3185|; HNRNPK|IDBG-73948|ENSG00000165119|3190|; RBMX|IDBG-87732|ENSG00000147274|101928747,26787,27316|; 
CDT1 association with the CDC6:ORC:origin complex	12959	REACTOME	9606	2	58	0.16494713842603062	0.20298372910520399	GMNN; UBC; 	GMNN|IDBG-65780|ENSG00000112312|51053|; UBC|IDBG-64029|ENSG00000150991|7316|; 
DNA Repair	19821	REACTOME	9606	3	112	0.16648003462736338	0.20396560533816044	PCNA; RAD51; UBC; 	PCNA|IDBG-50801|ENSG00000132646|5111|; RAD51|IDBG-6509|ENSG00000051180|5888|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Resolution of Sister Chromatid Cohesion	12939	REACTOME	9606	3	112	0.16648003462736338	0.20396560533816044	CCNB2; MIS12; TUBA4A; 	CCNB2|IDBG-14456|ENSG00000157456|9133|; MIS12|IDBG-21731|ENSG00000167842|79003|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; 
Innate Immune System	17476	REACTOME	9606	10	563	0.16968596659515106	0.2069795856270524	AKT2; APP; CYLD; EGFR; EP300; JAK2; MAP3K7; NCKIPSD; TAB1; UBC; 	AKT2|IDBG-51270|ENSG00000105221|208|; APP|IDBG-1100|ENSG00000142192|351|; CYLD|IDBG-30697|ENSG00000083799|102724054,1540|; EGFR|IDBG-16933|ENSG00000146648|1956|; EP300|IDBG-8992|ENSG00000100393|2033|; JAK2|IDBG-47039|ENSG00000096968|3717|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; NCKIPSD|IDBG-239383|ENSG00000213672|51517|; TAB1|IDBG-8281|ENSG00000100324|10454|; UBC|IDBG-64029|ENSG00000150991|7316|; 
IL5	15921	NETPATH	9606	2	59	0.1694079336754975	0.2070956017398703	JAK2; SHC1; 	JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Beta1 integrin cell surface interactions	14944	PID NCI	9606	2	60	0.17388922010983998	0.21071728637764453	CD81; IGSF8; 	CD81|IDBG-22455|ENSG00000110651|975|; IGSF8|IDBG-103984|ENSG00000162729|93185|; 
Cell death signalling via NRAGE, NRIF and NADE	18983	REACTOME	9606	2	60	0.17388922010983998	0.21071728637764453	UBC; YWHAE; 	UBC|IDBG-64029|ENSG00000150991|7316|; YWHAE|IDBG-14629|ENSG00000108953|7531|; 
PI3K Cascade	13278	REACTOME	9606	2	60	0.17388922010983998	0.21071728637764453	AKT2; PPM1A; 	AKT2|IDBG-51270|ENSG00000105221|208|; PPM1A|IDBG-8210|ENSG00000100614|5494|; 
Processing of Capped Intron-Containing Pre-mRNA	13751	REACTOME	9606	3	115	0.1757518495383414	0.2125104063045304	HNRNPF; HNRNPK; RBMX; 	HNRNPF|IDBG-71348|ENSG00000169813|3185|; HNRNPK|IDBG-73948|ENSG00000165119|3190|; RBMX|IDBG-87732|ENSG00000147274|101928747,26787,27316|; 
TCR signaling	17097	REACTOME	9606	2	61	0.17838979267301097	0.21523116289895888	MAP3K7; UBC; 	MAP3K7|IDBG-94374|ENSG00000135341|6885|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Cell Cycle Checkpoints	19894	REACTOME	9606	3	117	0.18201262273287278	0.21912582563285116	CCNB2; MCM2; UBC; 	CCNB2|IDBG-14456|ENSG00000157456|9133|; MCM2|IDBG-54871|ENSG00000073111|4171|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Interferon gamma signaling	13077	REACTOME	9606	2	63	0.1874441083608434	0.22517636393997423	ICAM1; JAK2; 	ICAM1|IDBG-26804|ENSG00000090339|3383|; JAK2|IDBG-47039|ENSG00000096968|3717|; 
HIF-1-alpha transcription factor network	15518	PID NCI	9606	2	64	0.19199557238712825	0.23014588050724877	SMAD3; SP1; 	SMAD3|IDBG-18366|ENSG00000166949|4088|; SP1|IDBG-36616|ENSG00000185591|6667|; 
Neurotrophin signaling pathway	4379	KEGG	9606	3	121	0.19471066449881808	0.23289745430354317	AKT2; SHC1; YWHAE; 	AKT2|IDBG-51270|ENSG00000105221|208|; SHC1|IDBG-103007|ENSG00000160691|6464|; YWHAE|IDBG-14629|ENSG00000108953|7531|; 
RNA Polymerase I Chain Elongation	13735	REACTOME	9606	2	65	0.19656176342817	0.23460597570459002	HIST2H2AC; HIST2H2BE; 	HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; 
Activation of NF-kappaB in B cells	13094	REACTOME	9606	2	66	0.20114160470823753	0.23904409124854784	MAP3K7; UBC; 	MAP3K7|IDBG-94374|ENSG00000135341|6885|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Semaphorin interactions	17105	REACTOME	9606	2	66	0.20114160470823753	0.23904409124854784	DPYSL2; DPYSL5; 	DPYSL2|IDBG-13200|ENSG00000092964|102723812,1808|; DPYSL5|IDBG-36183|ENSG00000157851|56896|; 
Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)	14943	PID NCI	9606	2	67	0.20573404375289328	0.24397947496336703	KPNB1; SHC1; 	KPNB1|IDBG-56053|ENSG00000108424|3837|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Signaling by the B Cell Receptor (BCR)	19561	REACTOME	9606	4	188	0.21122852738378173	0.24942943127233802	AKT2; EGFR; MAP3K7; UBC; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Systemic lupus erythematosus	2805	KEGG	9606	3	126	0.21088152692491088	0.24955063420751714	HIST2H2AC; HIST2H2BE; HIST3H3; 	HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; HIST3H3|IDBG-107261|ENSG00000168148|8290|; 
Signaling by SCF-KIT	13325	REACTOME	9606	3	127	0.2141515811233515	0.252344219795032	AKT2; EGFR; JAK2; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; JAK2|IDBG-47039|ENSG00000096968|3717|; 
Adipocytokine signaling pathway	590	KEGG	9606	2	70	0.21957677843124482	0.2565581305880861	AKT2; JAK2; 	AKT2|IDBG-51270|ENSG00000105221|208|; JAK2|IDBG-47039|ENSG00000096968|3717|; 
Orc1 removal from chromatin	12931	REACTOME	9606	2	70	0.21957677843124482	0.2565581305880861	MCM2; UBC; 	MCM2|IDBG-54871|ENSG00000073111|4171|; UBC|IDBG-64029|ENSG00000150991|7316|; 
RIG-I-like receptor signaling pathway	5713	KEGG	9606	2	70	0.21957677843124482	0.2565581305880861	CYLD; MAP3K7; 	CYLD|IDBG-30697|ENSG00000083799|102724054,1540|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; 
Switching of origins to a post-replicative state	12947	REACTOME	9606	2	70	0.21957677843124482	0.2565581305880861	MCM2; UBC; 	MCM2|IDBG-54871|ENSG00000073111|4171|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	13066	REACTOME	9606	2	71	0.224209555066116	0.2608727527498834	CD81; ICAM1; 	CD81|IDBG-22455|ENSG00000110651|975|; ICAM1|IDBG-26804|ENSG00000090339|3383|; 
NCAM signaling for neurite out-growth	13914	REACTOME	9606	2	71	0.224209555066116	0.2608727527498834	CACNB3; JAK2; 	CACNB3|IDBG-30418|ENSG00000167535|784|; JAK2|IDBG-47039|ENSG00000096968|3717|; 
Melanoma	490	KEGG	9606	2	72	0.22885001687976644	0.2657149777578878	AKT2; EGFR; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; 
Constitutive PI3K/AKT Signaling in Cancer	13715	REACTOME	9606	2	73	0.23349724841549302	0.2705448285398719	AKT2; EGFR; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; 
Spliceosome	8120	KEGG	9606	3	133	0.2339911485948195	0.2705522655627601	HNRNPK; PRPF31; RBMX; 	HNRNPK|IDBG-73948|ENSG00000165119|3190|; PRPF31|IDBG-68110|ENSG00000105618|26121|; RBMX|IDBG-87732|ENSG00000147274|101928747,26787,27316|; 
Downstream signaling of activated FGFR	16879	REACTOME	9606	3	134	0.23733081221935975	0.273843244868492	AKT2; EGFR; JAK2; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; JAK2|IDBG-47039|ENSG00000096968|3717|; 
B cell receptor signaling pathway	532	KEGG	9606	2	74	0.2381503556512911	0.2742187705113414	AKT2; CD81; 	AKT2|IDBG-51270|ENSG00000105221|208|; CD81|IDBG-22455|ENSG00000110651|975|; 
Transcriptional regulation by small RNAs	17771	REACTOME	9606	2	76	0.24747072592060435	0.28436077202057025	HIST2H2AC; HIST2H2BE; 	HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; 
Platelet degranulation 	13130	REACTOME	9606	2	78	0.25680438944439227	0.29386894049822204	APP; TUBA4A; 	APP|IDBG-1100|ENSG00000142192|351|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; 
Validated targets of C-MYC transcriptional activation	15279	PID NCI	9606	2	78	0.25680438944439227	0.29386894049822204	HUWE1; SMAD3; 	HUWE1|IDBG-70116|ENSG00000086758|10075|; SMAD3|IDBG-18366|ENSG00000166949|4088|; 
JAK STAT pathway and regulation	16125	INOH	9606	5	273	0.2591735809650423	0.29596983011440015	AKT2; CSNK1E; EGFR; JAK2; MAP3K7; 	AKT2|IDBG-51270|ENSG00000105221|208|; CSNK1E|IDBG-236645|ENSG00000213923|102800317,1454|; EGFR|IDBG-16933|ENSG00000146648|1956|; JAK2|IDBG-47039|ENSG00000096968|3717|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; 
Metabolism of lipids and lipoproteins	16920	REACTOME	9606	9	554	0.26082392454249426	0.2972428708851834	EP300; HDAC3; KPNB1; NCOA6; NCOR1; NCOR2; SP1; TBL1X; TBL1XR1; 	EP300|IDBG-8992|ENSG00000100393|2033|; HDAC3|IDBG-50725|ENSG00000171720|8841|; KPNB1|IDBG-56053|ENSG00000108424|3837|; NCOA6|IDBG-68724|ENSG00000198646|23054|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; SP1|IDBG-36616|ENSG00000185591|6667|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; 
CD4 T cell receptor signaling	16104	INOH	9606	2	79	0.26147418794028465	0.29737330800585654	AKT2; MAP3K7; 	AKT2|IDBG-51270|ENSG00000105221|208|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; 
Factors involved in megakaryocyte development and platelet production	13101	REACTOME	9606	3	142	0.2643232918784232	0.29999882820557233	EP300; JAK2; TUBA4A; 	EP300|IDBG-8992|ENSG00000100393|2033|; JAK2|IDBG-47039|ENSG00000096968|3717|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; 
IL2	15918	NETPATH	9606	2	81	0.2708158511776874	0.3054934906577571	JAK2; SHC1; 	JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
NoRC negatively regulates rRNA expression	17921	REACTOME	9606	2	81	0.2708158511776874	0.3054934906577571	HIST2H2AC; HIST2H2BE; 	HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; 
Unfolded Protein Response (UPR)	16784	REACTOME	9606	2	81	0.2708158511776874	0.3054934906577571	EIF2AK3; SHC1; 	EIF2AK3|IDBG-60518|ENSG00000172071|9451|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
TSH	15927	NETPATH	9606	2	82	0.27548622535796025	0.31013155187356584	JAK2; SHC1; 	JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Downstream signal transduction	13329	REACTOME	9606	3	146	0.277966887896254	0.3122907343773704	AKT2; EGFR; JAK2; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; JAK2|IDBG-47039|ENSG00000096968|3717|; 
Response to elevated platelet cytosolic Ca2+	13131	REACTOME	9606	2	83	0.2801553313826367	0.31411355336841085	APP; TUBA4A; 	APP|IDBG-1100|ENSG00000142192|351|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; 
DAP12 signaling	13003	REACTOME	9606	3	147	0.2813894936715948	0.3148612277978531	AKT2; EGFR; JAK2; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; JAK2|IDBG-47039|ENSG00000096968|3717|; 
Endocytosis	4386	KEGG	9606	4	214	0.2822021998332128	0.3151352533348755	EGFR; RABEP1; SMAD2; SMAD3; 	EGFR|IDBG-16933|ENSG00000146648|1956|; RABEP1|IDBG-21268|ENSG00000029725|9135|; SMAD2|IDBG-3127|ENSG00000175387|4087|; SMAD3|IDBG-18366|ENSG00000166949|4088|; 
PDGFR-beta signaling pathway	15816	PID NCI	9606	2	85	0.28948695633795596	0.31941403731126355	JAK2; SHC1; 	JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
PI-3K cascade	13309	REACTOME	9606	2	85	0.28948695633795596	0.31941403731126355	AKT2; EGFR; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; 
PI3K events in ERBB2 signaling	13286	REACTOME	9606	2	85	0.28948695633795596	0.31941403731126355	AKT2; EGFR; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; 
PI3K events in ERBB4 signaling	13263	REACTOME	9606	2	85	0.28948695633795596	0.31941403731126355	AKT2; EGFR; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; 
PI3K/AKT Signaling in Cancer	19195	REACTOME	9606	2	85	0.28948695633795596	0.31941403731126355	AKT2; EGFR; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; 
PIP3 activates AKT signaling	12989	REACTOME	9606	2	85	0.28948695633795596	0.31941403731126355	AKT2; EGFR; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; 
GAB1 signalosome	13212	REACTOME	9606	2	88	0.3034579438680649	0.3328441874442214	AKT2; EGFR; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; 
PI3K/AKT activation	13178	REACTOME	9606	2	88	0.3034579438680649	0.3328441874442214	AKT2; EGFR; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; 
Regulatory RNA pathways	19919	REACTOME	9606	2	88	0.3034579438680649	0.3328441874442214	HIST2H2AC; HIST2H2BE; 	HIST2H2AC|IDBG-102011|ENSG00000184260|8338|; HIST2H2BE|IDBG-101997|ENSG00000184678|8349|; 
DAP12 interactions	13004	REACTOME	9606	3	155	0.30888908080875105	0.33813301745336655	AKT2; EGFR; JAK2; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; JAK2|IDBG-47039|ENSG00000096968|3717|; 
Progesterone-mediated oocyte maturation	5712	KEGG	9606	2	91	0.3173821172407829	0.3467462107650286	AKT2; CCNB2; 	AKT2|IDBG-51270|ENSG00000105221|208|; CCNB2|IDBG-14456|ENSG00000157456|9133|; 
Jak-STAT signaling pathway	568	KEGG	9606	3	158	0.3192356352544491	0.34808600700632464	AKT2; EP300; JAK2; 	AKT2|IDBG-51270|ENSG00000105221|208|; EP300|IDBG-8992|ENSG00000100393|2033|; JAK2|IDBG-47039|ENSG00000096968|3717|; 
Formation of a pool of free 40S subunits	13447	REACTOME	9606	2	94	0.33124369732111086	0.3604710823788559	EIF1AX; RPS4Y1; 	EIF1AX|IDBG-50658|ENSG00000173674|1964|; RPS4Y1|IDBG-6|ENSG00000129824|6192|; 
RNA transport	10361	KEGG	9606	3	170	0.3606110561108349	0.3916617145626485	EIF1AX; EIF1AY; KPNB1; 	EIF1AX|IDBG-50658|ENSG00000173674|1964|; EIF1AY|IDBG-384|ENSG00000198692|9086|; KPNB1|IDBG-56053|ENSG00000108424|3837|; 
Role of LAT2/NTAL/LAB on calcium mobilization	17405	REACTOME	9606	2	101	0.3632643353787489	0.39377286354532354	AKT2; EGFR; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; 
Protein processing in endoplasmic reticulum	10363	KEGG	9606	3	171	0.3640490164638539	0.39385419909832153	DNAJB1; EIF2AK3; FBXO6; 	DNAJB1|IDBG-33491|ENSG00000132002|3337|; EIF2AK3|IDBG-60518|ENSG00000172071|9451|; FBXO6|IDBG-89462|ENSG00000116663|26270|; 
Alzheimer's disease	521	KEGG	9606	3	172	0.3674842669890682	0.3967972143559005	APP; EIF2AK3; NDUFS1; 	APP|IDBG-1100|ENSG00000142192|351|; EIF2AK3|IDBG-60518|ENSG00000172071|9451|; NDUFS1|IDBG-79438|ENSG00000023228|4719|; 
Separation of Sister Chromatids	12942	REACTOME	9606	3	173	0.3709165691118616	0.3997256230234625	MIS12; TUBA4A; UBC; 	MIS12|IDBG-21731|ENSG00000167842|79003|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Purine metabolism	503	KEGG	9606	3	174	0.37434568755103104	0.4018604576224802	PRIM1; PRIM2; PRPS1; 	PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; PRPS1|IDBG-81487|ENSG00000147224|5631|; 
Signaling by PDGF	13330	REACTOME	9606	3	174	0.37434568755103104	0.4018604576224802	AKT2; EGFR; JAK2; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; JAK2|IDBG-47039|ENSG00000096968|3717|; 
L13a-mediated translational silencing of Ceruloplasmin expression	13096	REACTOME	9606	2	104	0.3768184792736003	0.40295617725789623	EIF1AX; RPS4Y1; 	EIF1AX|IDBG-50658|ENSG00000173674|1964|; RPS4Y1|IDBG-6|ENSG00000129824|6192|; 
Pyrimidine metabolism	409	KEGG	9606	2	104	0.3768184792736003	0.40295617725789623	PRIM1; PRIM2; 	PRIM1|IDBG-41538|ENSG00000198056|5557|; PRIM2|IDBG-91619|ENSG00000146143|5558|; 
GTP hydrolysis and joining of the 60S ribosomal subunit	13444	REACTOME	9606	2	105	0.381310882352572	0.4061948938688627	EIF1AX; RPS4Y1; 	EIF1AX|IDBG-50658|ENSG00000173674|1964|; RPS4Y1|IDBG-6|ENSG00000129824|6192|; 
VEGFA-VEGFR2 Pathway	18745	REACTOME	9606	2	105	0.381310882352572	0.4061948938688627	AKT2; JAK2; 	AKT2|IDBG-51270|ENSG00000105221|208|; JAK2|IDBG-47039|ENSG00000096968|3717|; 
T cell receptor signaling pathway	563	KEGG	9606	2	107	0.3902549107813792	0.4149261982445699	AKT2; MAP3K7; 	AKT2|IDBG-51270|ENSG00000105221|208|; MAP3K7|IDBG-94374|ENSG00000135341|6885|; 
Chemokine signaling pathway	4389	KEGG	9606	3	181	0.39824131480511826	0.42180139258939053	AKT2; JAK2; SHC1; 	AKT2|IDBG-51270|ENSG00000105221|208|; JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Mitotic Anaphase	18656	REACTOME	9606	3	181	0.39824131480511826	0.42180139258939053	MIS12; TUBA4A; UBC; 	MIS12|IDBG-21731|ENSG00000167842|79003|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Mitotic Metaphase and Anaphase	19900	REACTOME	9606	3	182	0.401636895108063	0.4245875748285238	MIS12; TUBA4A; UBC; 	MIS12|IDBG-21731|ENSG00000167842|79003|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Cap-dependent Translation Initiation	18804	REACTOME	9606	2	112	0.41236059451638735	0.4334472158268844	EIF1AX; RPS4Y1; 	EIF1AX|IDBG-50658|ENSG00000173674|1964|; RPS4Y1|IDBG-6|ENSG00000129824|6192|; 
Eukaryotic Translation Initiation	16696	REACTOME	9606	2	112	0.41236059451638735	0.4334472158268844	EIF1AX; RPS4Y1; 	EIF1AX|IDBG-50658|ENSG00000173674|1964|; RPS4Y1|IDBG-6|ENSG00000129824|6192|; 
Hedgehog 'off' state	18085	REACTOME	9606	2	112	0.41236059451638735	0.4334472158268844	TUBA4A; UBC; 	TUBA4A|IDBG-81457|ENSG00000127824|7277|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Signaling by VEGF	17346	REACTOME	9606	2	114	0.4210942446940794	0.44179074821401526	AKT2; JAK2; 	AKT2|IDBG-51270|ENSG00000105221|208|; JAK2|IDBG-47039|ENSG00000096968|3717|; 
Host Interactions of HIV factors	19514	REACTOME	9606	2	121	0.4511310452935536	0.4724108115809854	KPNB1; UBC; 	KPNB1|IDBG-56053|ENSG00000108424|3837|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Huntington's disease	4392	KEGG	9606	3	198	0.4551356388664747	0.4757067411881233	EP300; NDUFS1; SP1; 	EP300|IDBG-8992|ENSG00000100393|2033|; NDUFS1|IDBG-79438|ENSG00000023228|4719|; SP1|IDBG-36616|ENSG00000185591|6667|; 
Axon guidance	494	KEGG	9606	2	128	0.4802794864184593	0.5001034051824482	DPYSL2; DPYSL5; 	DPYSL2|IDBG-13200|ENSG00000092964|102723812,1808|; DPYSL5|IDBG-36183|ENSG00000157851|56896|; 
Signaling by Hedgehog	16836	REACTOME	9606	2	128	0.4802794864184593	0.5001034051824482	TUBA4A; UBC; 	TUBA4A|IDBG-81457|ENSG00000127824|7277|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Natural killer cell mediated cytotoxicity	578	KEGG	9606	2	130	0.48843478409161445	0.5076428935783633	ICAM1; SHC1; 	ICAM1|IDBG-26804|ENSG00000090339|3383|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Influenza Life Cycle	19285	REACTOME	9606	2	131	0.49248278550586755	0.5108933569266476	KPNB1; RPS4Y1; 	KPNB1|IDBG-56053|ENSG00000108424|3837|; RPS4Y1|IDBG-6|ENSG00000129824|6192|; 
Focal adhesion	546	KEGG	9606	3	210	0.493957177496952	0.5114668535649409	AKT2; EGFR; SHC1; 	AKT2|IDBG-51270|ENSG00000105221|208|; EGFR|IDBG-16933|ENSG00000146648|1956|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Gastrin-CREB signalling pathway via PKC and MAPK	13219	REACTOME	9606	3	212	0.5002982691600699	0.5170680435453237	APP; EGFR; JAK2; 	APP|IDBG-1100|ENSG00000142192|351|; EGFR|IDBG-16933|ENSG00000146648|1956|; JAK2|IDBG-47039|ENSG00000096968|3717|; 
Tight junction	522	KEGG	9606	2	135	0.508473784452335	0.5245407999461821	AKT2; CSNK2A1; 	AKT2|IDBG-51270|ENSG00000105221|208|; CSNK2A1|IDBG-37787|ENSG00000101266|1457|; 
Influenza Infection	16853	REACTOME	9606	2	136	0.5124206290269812	0.5276316310018081	KPNB1; RPS4Y1; 	KPNB1|IDBG-56053|ENSG00000108424|3837|; RPS4Y1|IDBG-6|ENSG00000129824|6192|; 
Insulin signaling pathway	531	KEGG	9606	2	143	0.539466017618018	0.5534263212162662	AKT2; SHC1; 	AKT2|IDBG-51270|ENSG00000105221|208|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
beta-catenin independent WNT signaling	17081	REACTOME	9606	2	143	0.539466017618018	0.5534263212162662	MAP3K7; UBC; 	MAP3K7|IDBG-94374|ENSG00000135341|6885|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Cell adhesion molecules (CAMs)	440	KEGG	9606	2	144	0.5432453267773583	0.5562751962388078	ICAM1; NLGN3; 	ICAM1|IDBG-26804|ENSG00000090339|3383|; NLGN3|IDBG-75254|ENSG00000196338|54413|; 
Translation	17867	REACTOME	9606	2	145	0.5470033224321431	0.5590917936461131	EIF1AX; RPS4Y1; 	EIF1AX|IDBG-50658|ENSG00000173674|1964|; RPS4Y1|IDBG-6|ENSG00000129824|6192|; 
Phagosome	10394	KEGG	9606	2	152	0.5727076619701287	0.5842881477820246	TUBA4A; TUBB8; 	TUBA4A|IDBG-81457|ENSG00000127824|7277|; TUBB8|IDBG-777287|ENSG00000261456|347688|; 
Hemostasis	19856	REACTOME	9606	6	508	0.620618550833975	0.6285461600599563	AKT2; APP; EP300; JAK2; SHC1; TUBA4A; 	AKT2|IDBG-51270|ENSG00000105221|208|; APP|IDBG-1100|ENSG00000142192|351|; EP300|IDBG-8992|ENSG00000100393|2033|; JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; TUBA4A|IDBG-81457|ENSG00000127824|7277|; 
Glycogen storage diseases	19851	REACTOME	9606	3	253	0.6205348621318492	0.6296103262946551	HS2ST1; PRPS1; UBC; 	HS2ST1|IDBG-100108|ENSG00000153936|9653|; PRPS1|IDBG-81487|ENSG00000147224|5631|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Metabolism of carbohydrates	17445	REACTOME	9606	3	253	0.6205348621318492	0.6296103262946551	HS2ST1; PRPS1; UBC; 	HS2ST1|IDBG-100108|ENSG00000153936|9653|; PRPS1|IDBG-81487|ENSG00000147224|5631|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Myoclonic epilepsy of Lafora	17077	REACTOME	9606	3	253	0.6205348621318492	0.6296103262946551	HS2ST1; PRPS1; UBC; 	HS2ST1|IDBG-100108|ENSG00000153936|9653|; PRPS1|IDBG-81487|ENSG00000147224|5631|; UBC|IDBG-64029|ENSG00000150991|7316|; 
HIV Infection	19164	REACTOME	9606	2	209	0.7429294556208107	0.7510489032232239	KPNB1; UBC; 	KPNB1|IDBG-56053|ENSG00000108424|3837|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Regulation of actin cytoskeleton	404	KEGG	9606	2	217	0.7615563161596204	0.7684795553974351	EGFR; TMSB4Y; 	EGFR|IDBG-16933|ENSG00000146648|1956|; TMSB4Y|IDBG-220|ENSG00000154620|9087|; 
Extracellular matrix organization	17095	REACTOME	9606	2	266	0.8520468779763282	0.8582323362556482	APP; ICAM1; 	APP|IDBG-1100|ENSG00000142192|351|; ICAM1|IDBG-26804|ENSG00000090339|3383|; 
Metabolism	19429	REACTOME	9606	14	1535	0.9310111169935029	0.9360709600206414	CACNB3; EP300; HDAC3; HS2ST1; KPNB1; NCOA6; NCOR1; NCOR2; NDUFS1; PRPS1; SP1; TBL1X; TBL1XR1; UBC; 	CACNB3|IDBG-30418|ENSG00000167535|784|; EP300|IDBG-8992|ENSG00000100393|2033|; HDAC3|IDBG-50725|ENSG00000171720|8841|; HS2ST1|IDBG-100108|ENSG00000153936|9653|; KPNB1|IDBG-56053|ENSG00000108424|3837|; NCOA6|IDBG-68724|ENSG00000198646|23054|; NCOR1|IDBG-31971|ENSG00000141027|9611|; NCOR2|IDBG-63911|ENSG00000196498|9612|; NDUFS1|IDBG-79438|ENSG00000023228|4719|; PRPS1|IDBG-81487|ENSG00000147224|5631|; SP1|IDBG-36616|ENSG00000185591|6667|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; UBC|IDBG-64029|ENSG00000150991|7316|; 
Transmembrane transport of small molecules	16726	REACTOME	9606	4	606	0.9514097330535254	0.9548506362472091	NCOA6; TBL1X; TBL1XR1; UBC; 	NCOA6|IDBG-68724|ENSG00000198646|23054|; TBL1X|IDBG-42498|ENSG00000101849|6907|; TBL1XR1|IDBG-65899|ENSG00000177565|79718|; UBC|IDBG-64029|ENSG00000150991|7316|; 
GPCR downstream signaling	18003	REACTOME	9606	4	923	0.9978743887850438	0.9978743887850438	AKT2; APP; JAK2; SHC1; 	AKT2|IDBG-51270|ENSG00000105221|208|; APP|IDBG-1100|ENSG00000142192|351|; JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
Signaling by GPCR	17449	REACTOME	9606	5	1035	0.9975604498001811	0.9993611004315894	AKT2; APP; EGFR; JAK2; SHC1; 	AKT2|IDBG-51270|ENSG00000105221|208|; APP|IDBG-1100|ENSG00000142192|351|; EGFR|IDBG-16933|ENSG00000146648|1956|; JAK2|IDBG-47039|ENSG00000096968|3717|; SHC1|IDBG-103007|ENSG00000160691|6464|; 
